CN116419682A - Nicotine pouch compositions - Google Patents
Nicotine pouch compositions Download PDFInfo
- Publication number
- CN116419682A CN116419682A CN202180075476.XA CN202180075476A CN116419682A CN 116419682 A CN116419682 A CN 116419682A CN 202180075476 A CN202180075476 A CN 202180075476A CN 116419682 A CN116419682 A CN 116419682A
- Authority
- CN
- China
- Prior art keywords
- nicotine
- composition
- pouch composition
- pouch
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 598
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims abstract description 378
- 229960002715 nicotine Drugs 0.000 title claims abstract description 375
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title claims abstract description 375
- 239000003456 ion exchange resin Substances 0.000 claims abstract description 177
- 229920003303 ion-exchange polymer Polymers 0.000 claims abstract description 177
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 160
- 150000001768 cations Chemical class 0.000 claims abstract description 154
- 239000000835 fiber Substances 0.000 claims description 338
- 235000002639 sodium chloride Nutrition 0.000 claims description 90
- 150000003839 salts Chemical class 0.000 claims description 77
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 76
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 61
- 150000005846 sugar alcohols Chemical class 0.000 claims description 43
- 239000003906 humectant Substances 0.000 claims description 42
- 235000019895 oat fiber Nutrition 0.000 claims description 39
- 239000000872 buffer Substances 0.000 claims description 38
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 38
- 235000017550 sodium carbonate Nutrition 0.000 claims description 38
- 229920003043 Cellulose fiber Polymers 0.000 claims description 35
- 239000001913 cellulose Substances 0.000 claims description 35
- 238000005342 ion exchange Methods 0.000 claims description 35
- -1 oxygen ions Chemical class 0.000 claims description 32
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 31
- 239000003002 pH adjusting agent Substances 0.000 claims description 31
- 235000019814 powdered cellulose Nutrition 0.000 claims description 30
- 229920003124 powdered cellulose Polymers 0.000 claims description 30
- 239000008363 phosphate buffer Substances 0.000 claims description 27
- 239000012458 free base Substances 0.000 claims description 26
- 235000021307 Triticum Nutrition 0.000 claims description 24
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 23
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 22
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 22
- 229960000281 trometamol Drugs 0.000 claims description 20
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 19
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 19
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 19
- 239000011425 bamboo Substances 0.000 claims description 19
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 235000011430 Malus pumila Nutrition 0.000 claims description 18
- 235000015103 Malus silvestris Nutrition 0.000 claims description 18
- 244000299461 Theobroma cacao Species 0.000 claims description 18
- 240000008042 Zea mays Species 0.000 claims description 18
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 18
- 235000005822 corn Nutrition 0.000 claims description 18
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 18
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 17
- 241000335053 Beta vulgaris Species 0.000 claims description 17
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 17
- 240000005979 Hordeum vulgare Species 0.000 claims description 17
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 17
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 17
- 240000007594 Oryza sativa Species 0.000 claims description 17
- 235000007164 Oryza sativa Nutrition 0.000 claims description 17
- 240000003768 Solanum lycopersicum Species 0.000 claims description 17
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 17
- 244000061456 Solanum tuberosum Species 0.000 claims description 17
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 17
- 235000009566 rice Nutrition 0.000 claims description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 16
- 241000196324 Embryophyta Species 0.000 claims description 16
- 239000011347 resin Substances 0.000 claims description 15
- 229920005989 resin Polymers 0.000 claims description 15
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 14
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 14
- 150000001449 anionic compounds Chemical class 0.000 claims description 14
- 239000011575 calcium Substances 0.000 claims description 14
- 229910052791 calcium Inorganic materials 0.000 claims description 14
- 229910052749 magnesium Inorganic materials 0.000 claims description 14
- 239000011777 magnesium Substances 0.000 claims description 14
- 229910001412 inorganic anion Inorganic materials 0.000 claims description 13
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 12
- 235000011181 potassium carbonates Nutrition 0.000 claims description 12
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 9
- 239000001095 magnesium carbonate Substances 0.000 claims description 9
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 9
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 9
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 9
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 9
- 239000011736 potassium bicarbonate Substances 0.000 claims description 9
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 9
- 239000011701 zinc Substances 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 8
- 125000000524 functional group Chemical group 0.000 claims description 8
- 235000010449 maltitol Nutrition 0.000 claims description 8
- 239000000845 maltitol Substances 0.000 claims description 8
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 8
- 229940035436 maltitol Drugs 0.000 claims description 8
- 239000000600 sorbitol Substances 0.000 claims description 8
- 235000010356 sorbitol Nutrition 0.000 claims description 8
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 7
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 7
- 239000004386 Erythritol Substances 0.000 claims description 7
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 7
- 229930195725 Mannitol Natural products 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 235000019414 erythritol Nutrition 0.000 claims description 7
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 7
- 229940009714 erythritol Drugs 0.000 claims description 7
- 239000000905 isomalt Substances 0.000 claims description 7
- 235000010439 isomalt Nutrition 0.000 claims description 7
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 7
- 239000000832 lactitol Substances 0.000 claims description 7
- 235000010448 lactitol Nutrition 0.000 claims description 7
- 229960003451 lactitol Drugs 0.000 claims description 7
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 7
- 235000010355 mannitol Nutrition 0.000 claims description 7
- 239000000594 mannitol Substances 0.000 claims description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 7
- 239000000811 xylitol Substances 0.000 claims description 7
- 235000010447 xylitol Nutrition 0.000 claims description 7
- 229960002675 xylitol Drugs 0.000 claims description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 229960001855 mannitol Drugs 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 150000001450 anions Chemical class 0.000 claims description 5
- 238000000338 in vitro Methods 0.000 claims description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 4
- 229910002651 NO3 Inorganic materials 0.000 claims description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- JOOXCMJARBKPKM-UHFFFAOYSA-M 4-oxopentanoate Chemical compound CC(=O)CCC([O-])=O JOOXCMJARBKPKM-UHFFFAOYSA-M 0.000 claims description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 3
- 150000007942 carboxylates Chemical class 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 229940058352 levulinate Drugs 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 3
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 229910052788 barium Inorganic materials 0.000 claims description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 229910017052 cobalt Inorganic materials 0.000 claims description 2
- 239000010941 cobalt Substances 0.000 claims description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
- 239000011133 lead Substances 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims description 2
- 125000005395 methacrylic acid group Chemical group 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229920005990 polystyrene resin Polymers 0.000 claims description 2
- 244000061176 Nicotiana tabacum Species 0.000 claims 6
- 240000008620 Fagopyrum esculentum Species 0.000 claims 1
- 244000082204 Phyllostachys viridis Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 89
- 239000000796 flavoring agent Substances 0.000 description 43
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 39
- 238000002474 experimental method Methods 0.000 description 39
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 39
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 39
- 239000003755 preservative agent Substances 0.000 description 37
- 235000011187 glycerol Nutrition 0.000 description 35
- 229960005150 glycerol Drugs 0.000 description 35
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 32
- 239000007788 liquid Substances 0.000 description 31
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 29
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 29
- 244000246386 Mentha pulegium Species 0.000 description 29
- 235000016257 Mentha pulegium Nutrition 0.000 description 29
- 235000004357 Mentha x piperita Nutrition 0.000 description 29
- 239000008123 high-intensity sweetener Substances 0.000 description 29
- 235000001050 hortel pimenta Nutrition 0.000 description 29
- 229940041616 menthol Drugs 0.000 description 29
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 29
- 235000010241 potassium sorbate Nutrition 0.000 description 28
- 239000004302 potassium sorbate Substances 0.000 description 28
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 27
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 27
- 239000004376 Sucralose Substances 0.000 description 27
- 235000010358 acesulfame potassium Nutrition 0.000 description 27
- 229960004998 acesulfame potassium Drugs 0.000 description 27
- 239000000619 acesulfame-K Substances 0.000 description 27
- 229940069338 potassium sorbate Drugs 0.000 description 27
- 235000019408 sucralose Nutrition 0.000 description 27
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 27
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 25
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 25
- 239000000463 material Substances 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 25
- 235000010413 sodium alginate Nutrition 0.000 description 25
- 239000000661 sodium alginate Substances 0.000 description 25
- 229940005550 sodium alginate Drugs 0.000 description 25
- 235000013355 food flavoring agent Nutrition 0.000 description 24
- 239000004615 ingredient Substances 0.000 description 24
- 241000209140 Triticum Species 0.000 description 23
- 230000002335 preservative effect Effects 0.000 description 21
- 235000019634 flavors Nutrition 0.000 description 19
- 241001330002 Bambuseae Species 0.000 description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 241000219051 Fagopyrum Species 0.000 description 16
- 241000208125 Nicotiana Species 0.000 description 16
- 235000019359 magnesium stearate Nutrition 0.000 description 16
- 239000011342 resin composition Substances 0.000 description 15
- 235000019640 taste Nutrition 0.000 description 15
- 229920002472 Starch Polymers 0.000 description 14
- 239000008107 starch Substances 0.000 description 14
- 235000019698 starch Nutrition 0.000 description 14
- 239000000454 talc Substances 0.000 description 14
- 235000012222 talc Nutrition 0.000 description 14
- 229910052623 talc Inorganic materials 0.000 description 14
- 150000004683 dihydrates Chemical class 0.000 description 13
- 150000004687 hexahydrates Chemical class 0.000 description 13
- 239000000377 silicon dioxide Substances 0.000 description 13
- 150000004685 tetrahydrates Chemical class 0.000 description 13
- 235000003599 food sweetener Nutrition 0.000 description 12
- 239000003765 sweetening agent Substances 0.000 description 12
- 239000001226 triphosphate Substances 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 210000003296 saliva Anatomy 0.000 description 9
- 210000000214 mouth Anatomy 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 7
- 239000003607 modifier Substances 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 6
- 229940072056 alginate Drugs 0.000 description 6
- 235000010443 alginic acid Nutrition 0.000 description 6
- 229920000615 alginic acid Polymers 0.000 description 6
- 150000001767 cationic compounds Chemical class 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 229910001411 inorganic cation Inorganic materials 0.000 description 6
- 235000019831 pentapotassium triphosphate Nutrition 0.000 description 6
- ATGAWOHQWWULNK-UHFFFAOYSA-I pentapotassium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [K+].[K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O ATGAWOHQWWULNK-UHFFFAOYSA-I 0.000 description 6
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 6
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 6
- 235000019828 potassium polyphosphate Nutrition 0.000 description 6
- 229960004063 propylene glycol Drugs 0.000 description 6
- 235000013772 propylene glycol Nutrition 0.000 description 6
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 6
- 235000019830 sodium polyphosphate Nutrition 0.000 description 6
- 235000019832 sodium triphosphate Nutrition 0.000 description 6
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 5
- 229920001661 Chitosan Polymers 0.000 description 5
- 235000010980 cellulose Nutrition 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000008447 perception Effects 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 4
- 229910000393 dicalcium diphosphate Inorganic materials 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 235000010987 pectin Nutrition 0.000 description 4
- 239000001814 pectin Substances 0.000 description 4
- 229920001277 pectin Polymers 0.000 description 4
- 235000011007 phosphoric acid Nutrition 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical class [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000001361 adipic acid Substances 0.000 description 3
- 235000011037 adipic acid Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000003833 bile salt Substances 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- 235000019788 craving Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000019264 food flavour enhancer Nutrition 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 235000011087 fumaric acid Nutrition 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 235000012209 glucono delta-lactone Nutrition 0.000 description 3
- 239000000182 glucono-delta-lactone Substances 0.000 description 3
- 229960003681 gluconolactone Drugs 0.000 description 3
- 125000005456 glyceride group Chemical group 0.000 description 3
- 239000001087 glyceryl triacetate Substances 0.000 description 3
- 235000013773 glyceryl triacetate Nutrition 0.000 description 3
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 239000000395 magnesium oxide Substances 0.000 description 3
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 3
- 235000012245 magnesium oxide Nutrition 0.000 description 3
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 235000019426 modified starch Nutrition 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 229960000292 pectin Drugs 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 235000019643 salty taste Nutrition 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical class [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229960002622 triacetin Drugs 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- MLKLDGSYMHFAOC-AREMUKBSSA-N 1,2-dicapryl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC MLKLDGSYMHFAOC-AREMUKBSSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 2
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methoxysalicylic acid Chemical compound COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 239000004097 EU approved flavor enhancer Substances 0.000 description 2
- 244000004281 Eucalyptus maculata Species 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 244000078639 Mentha spicata Species 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- 108050004114 Monellin Proteins 0.000 description 2
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical class [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- 239000004283 Sodium sorbate Substances 0.000 description 2
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 229940093761 bile salts Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000004301 calcium benzoate Substances 0.000 description 2
- 235000010237 calcium benzoate Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 235000010244 calcium sorbate Nutrition 0.000 description 2
- 239000004303 calcium sorbate Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical group [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- IBIKHMZPHNKTHM-RDTXWAMCSA-N merck compound 25 Chemical compound C1C[C@@H](C(O)=O)[C@H](O)CN1C(C1=C(F)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 IBIKHMZPHNKTHM-RDTXWAMCSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 150000002891 organic anions Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 229950004354 phosphorylcholine Drugs 0.000 description 2
- 239000004300 potassium benzoate Substances 0.000 description 2
- 235000010235 potassium benzoate Nutrition 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 208000026451 salivation Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- OABYVIYXWMZFFJ-ZUHYDKSRSA-M sodium glycocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 OABYVIYXWMZFFJ-ZUHYDKSRSA-M 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- 235000019250 sodium sorbate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 description 2
- 229940117972 triolein Drugs 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
- MTIRIKBRVALRPJ-NTMALXAHSA-N (Z)-[3-aminopropyl(propan-2-yl)amino]-hydroxyimino-oxidoazanium Chemical compound CC(C)N(CCCN)[N+](\[O-])=N\O MTIRIKBRVALRPJ-NTMALXAHSA-N 0.000 description 1
- DPKCLDSTXVCYSN-NTMALXAHSA-N (Z)-[ethyl-[2-(ethylamino)ethyl]amino]-hydroxyimino-oxidoazanium Chemical compound CCNCCN(CC)[N+](\[O-])=N\O DPKCLDSTXVCYSN-NTMALXAHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- OIQOAYVCKAHSEJ-UHFFFAOYSA-N 2-[2,3-bis(2-hydroxyethoxy)propoxy]ethanol;hexadecanoic acid;octadecanoic acid Chemical compound OCCOCC(OCCO)COCCO.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O OIQOAYVCKAHSEJ-UHFFFAOYSA-N 0.000 description 1
- ZIIQCSMRQKCOCT-UHFFFAOYSA-N 2-acetamido-3-methyl-3-nitrososulfanylbutanoic acid Chemical compound CC(=O)NC(C(O)=O)C(C)(C)SN=O ZIIQCSMRQKCOCT-UHFFFAOYSA-N 0.000 description 1
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 1
- CIHKVMHPDDJIIP-UHFFFAOYSA-N 2-methylperoxybenzoic acid Chemical compound COOC1=CC=CC=C1C(O)=O CIHKVMHPDDJIIP-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 239000004377 Alitame Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 108010039627 Aprotinin Chemical class 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical class [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 229940123150 Chelating agent Drugs 0.000 description 1
- 239000005714 Chitosan hydrochloride Substances 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- UDKCHVLMFQVBAA-UHFFFAOYSA-M Choline salicylate Chemical compound C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O UDKCHVLMFQVBAA-UHFFFAOYSA-M 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- IEPRKVQEAMIZSS-UHFFFAOYSA-N Di-Et ester-Fumaric acid Natural products CCOC(=O)C=CC(=O)OCC IEPRKVQEAMIZSS-UHFFFAOYSA-N 0.000 description 1
- IEPRKVQEAMIZSS-WAYWQWQTSA-N Diethyl maleate Chemical compound CCOC(=O)\C=C/C(=O)OCC IEPRKVQEAMIZSS-WAYWQWQTSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical class [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010007979 Glycocholic Acid Proteins 0.000 description 1
- 108010035713 Glycodeoxycholic Acid Proteins 0.000 description 1
- WVULKSPCQVQLCU-UHFFFAOYSA-N Glycodeoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 WVULKSPCQVQLCU-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920002884 Laureth 4 Chemical class 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- VEYYWZRYIYDQJM-ZETCQYMHSA-N N(2)-acetyl-L-lysine Chemical compound CC(=O)N[C@H](C([O-])=O)CCCC[NH3+] VEYYWZRYIYDQJM-ZETCQYMHSA-N 0.000 description 1
- KTHDTJVBEPMMGL-VKHMYHEASA-N N-acetyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(C)=O KTHDTJVBEPMMGL-VKHMYHEASA-N 0.000 description 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
- CBQJSKKFNMDLON-JTQLQIEISA-N N-acetyl-L-phenylalanine Chemical compound CC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CBQJSKKFNMDLON-JTQLQIEISA-N 0.000 description 1
- GNMSLDIYJOSUSW-LURJTMIESA-N N-acetyl-L-proline Chemical compound CC(=O)N1CCC[C@H]1C(O)=O GNMSLDIYJOSUSW-LURJTMIESA-N 0.000 description 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
- RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 244000068689 Pimpinella saxifraga Species 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Chemical class 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- MEESPVWIOBCLJW-KTKRTIGZSA-N [(z)-octadec-9-enyl] dihydrogen phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOP(O)(O)=O MEESPVWIOBCLJW-KTKRTIGZSA-N 0.000 description 1
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229940068372 acetyl salicylate Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000019409 alitame Nutrition 0.000 description 1
- 108010009985 alitame Proteins 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910000316 alkaline earth metal phosphate Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical class [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229940119201 cedar leaf oil Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 229940009025 chenodeoxycholate Drugs 0.000 description 1
- RUDATBOHQWOJDD-BSWAIDMHSA-M chenodeoxycholate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-M 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- RPKLZQLYODPWTM-KBMWBBLPSA-N cholanoic acid Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC(O)=O)C)[C@@]1(C)CC2 RPKLZQLYODPWTM-KBMWBBLPSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 229960002688 choline salicylate Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-M deoxycholate Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-M 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical group O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- SPBWMYPZWNFWES-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide;dihydrate Chemical compound O.O.[Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N SPBWMYPZWNFWES-UHFFFAOYSA-N 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229960003668 docetaxel Drugs 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229960000878 docusate sodium Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
- 229960004675 fusidic acid Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 229940068939 glyceryl monolaurate Drugs 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 description 1
- 229940099347 glycocholic acid Drugs 0.000 description 1
- WVULKSPCQVQLCU-BUXLTGKBSA-N glycodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 WVULKSPCQVQLCU-BUXLTGKBSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000010514 hydrogenated cottonseed oil Substances 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical class C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940062711 laureth-9 Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 229940074096 monoolein Drugs 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KIWSYRHAAPLJFJ-DNZSEPECSA-N n-[(e,2z)-4-ethyl-2-hydroxyimino-5-nitrohex-3-enyl]pyridine-3-carboxamide Chemical compound [O-][N+](=O)C(C)C(/CC)=C/C(=N/O)/CNC(=O)C1=CC=CN=C1 KIWSYRHAAPLJFJ-DNZSEPECSA-N 0.000 description 1
- KCXCCSJYRGUQFM-UHFFFAOYSA-N n-[ethyl-[2-(ethylamino)ethyl]amino]-n-hydroxynitrous amide Chemical compound CCNCCN(CC)N(O)N=O KCXCCSJYRGUQFM-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960001698 nicotine polacrilex Drugs 0.000 description 1
- 229920000847 nonoxynol Polymers 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical class CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000002888 oleic acid derivatives Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229960005113 oxaceprol Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical class CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Chemical class 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Chemical class 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Chemical class 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229960000581 salicylamide Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Chemical class 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- 229940083618 sodium nitroprusside Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- GWLWWNLFFNJPDP-UHFFFAOYSA-M sodium;2-aminoethanesulfonate Chemical compound [Na+].NCCS([O-])(=O)=O GWLWWNLFFNJPDP-UHFFFAOYSA-M 0.000 description 1
- FIWQZURFGYXCEO-UHFFFAOYSA-M sodium;decanoate Chemical compound [Na+].CCCCCCCCCC([O-])=O FIWQZURFGYXCEO-UHFFFAOYSA-M 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 229940097346 sulfobutylether-beta-cyclodextrin Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- AWDRATDZQPNJFN-VAYUFCLWSA-N taurodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 AWDRATDZQPNJFN-VAYUFCLWSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 239000001789 thuja occidentalis l. leaf oil Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- HDOZVRUNCMBHFH-UHFFFAOYSA-N zotepine Chemical compound CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12 HDOZVRUNCMBHFH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/42—Treatment of tobacco products or tobacco substitutes by chemical substances by organic and inorganic substances
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Manufacture Of Tobacco Products (AREA)
Abstract
A pouch composition is disclosed comprising a nicotine-ion exchange resin combination, water in an amount of at least 15% by weight of the pouch composition, and an inorganic divalent cation. In addition, an oral pouch nicotine product comprising a saliva-permeable pouch and a pouch composition in the pouch and a pouch composition are disclosed.
Description
Technical Field
The present invention relates to a pouch composition and an oral pouch nicotine product according to the claims.
Background
Delivery of nicotine by smoking has many well known drawbacks, particularly health related problems, such as the introduction of carcinogens.
However, tobacco substitutes also suffer from drawbacks such as inadequate relief from craving for the user.
Another challenge in the prior art is that the desired release of nicotine should be attractive to the user of the pouch from the point of view of the user.
Yet another challenge associated with the prior art may be that the pouch as a delivery vehicle for nicotine may be somewhat expensive and thus places restrictions on the design of the pouch in order to control manufacturing costs.
It is an object of an embodiment of the present invention to provide a nicotine-containing pouch, e.g. as a tobacco substitute, which solves the above-mentioned problems.
Disclosure of Invention
The present invention relates to a pouch composition comprising
A nicotine-ion exchange resin combination, wherein,
water in an amount of at least 15% by weight of the pouch composition, and
inorganic divalent cations.
An advantage of the present invention may be that a relatively high stability of the provided nicotine may be obtained while a relatively fast release of nicotine is obtained. Achieving high stability may result in nicotine being too effectively e.g. bound to the carrier and thus slow release. By means of the claimed pouch composition comprising water in an amount of at least 15% by weight of the composition in combination with divalent inorganic cations, a high stability is facilitated but still a fast release is achieved, while also having a very desirable mouthfeel and taste. The high water content contributes to an efficient release of nicotine during use.
An advantage of the present invention is that a relatively fast release rate of nicotine from the pouch composition can be obtained due to the presence of divalent cations. At the same time, the desired moist mouthfeel is provided due to the high water content, which also promotes rapid nicotine release.
Furthermore, the present invention may advantageously provide more efficient nicotine release during use of the pouch comprising the pouch composition. Due to the minimization of any residual nicotine not released from the pouch composition, obtaining an effective release of nicotine may result in a lower total dose of nicotine and the same amount of nicotine released.
In an advantageous embodiment of the invention, the solid oral nicotine formulation comprises inorganic divalent cations in a molar ratio of at least 0.1, such as at least 0.25, such as at least 0.5, relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an advantageous embodiment of the invention, the pouch composition comprises inorganic divalent cations in a molar ratio of at least 0.1 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.25 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
The amount of divalent cations should advantageously be high enough to enable ion exchange of the complexed nicotine with the divalent cations during use of the pouch comprising the pouch composition.
Furthermore, the amount of inorganic divalent cations can also advantageously reduce the probability of the exchanged nicotine re-complexing with the ion exchange resin, simply by occupying binding sites on the ion exchange resin during use.
In one embodiment of the invention, the amount of inorganic divalent cations may even prevent re-complexation of nicotine exchanged during use with the ion exchange resin.
In addition, the amount of inorganic divalent cations can reduce the probability of complexing/re-complexing any uncomplexed nicotine, such as free base nicotine, and/or exchanged nicotine with the ion exchange resin during use.
In an advantageous embodiment of the invention, the solid oral nicotine formulation comprises inorganic divalent cations in a molar ratio of at most 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 6 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an advantageous embodiment of the invention, the pouch composition comprises inorganic divalent cations in a molar ratio of at most 5 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 with respect to the amount of nicotine in the nicotine-ion exchange resin combination.
One advantage of the above embodiments may be that the inclusion of inorganic divalent cations in a not too high amount will promote the desired taste and mouthfeel by avoiding or minimizing undesirable tastes and/or mouthfeel such as undesirable salty taste, localized dehydration, or even a mouth dehydration sensation.
In one embodiment of the invention, the pouch composition comprises an inorganic divalent cation in a molar ratio of between 0.1 and 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 6.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 3.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 2.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In one embodiment of the invention, the pouch composition comprises the inorganic divalent cation in a molar ratio of between 0.1 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.5 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.75 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 1.0 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 2.0 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In one embodiment of the invention, the pouch composition comprises the inorganic divalent cation in a molar ratio of between 0.01 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.01 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.01 and 3.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.01 and 2.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.01 and 1.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
Here, the molar ratio refers to the molar content of divalent cations divided by the molar content of nicotine.
In an advantageous embodiment of the invention, the inorganic divalent cations are selected from divalent cations of calcium, magnesium, iron, zinc and any combination thereof.
In an advantageous embodiment of the invention, the inorganic divalent cations are selected from divalent cations of calcium and magnesium.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt comprising an inorganic or organic anion.
In an advantageous embodiment of the invention, the inorganic divalent cation is provided as a salt comprising an anion selected from the group consisting of: carboxylate, such as acetate, lactate, oxalate, propionate or levulinate; an organic sulfonate group; organic sulfate radicals; an organic phosphate group; chloride, bromide, nitrate, sulfate, hydrogen phosphate, oxygen ions, and any combination thereof.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 10.0 wt% of the composition.
In one embodiment of the invention, the organic anion is selected from carboxylates, such as acetate, lactate, oxalate, propionate, levulinate; an organic sulfonate group; organic sulfate radicals; an organic phosphate group; and any combination thereof.
In an advantageous embodiment of the invention, the inorganic divalent cations are provided as inorganic salts.
In an advantageous embodiment of the invention, the inorganic divalent cation is provided as inorganic salt in an amount of between 0.1 and 15.0 wt.% of the composition, such as between 0.1 and 10.0 wt.% of the composition, such as between 0.5 and 10.0 wt.% of the composition.
In one embodiment of the invention, the inorganic divalent cation is provided as an inorganic salt in an amount of between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 10.0 wt% of the composition.
In one embodiment of the invention, the inorganic divalent cation is provided as an inorganic salt in an amount of between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 7.0 wt% of the composition, such as between 0.1 and 7.0 wt% of the composition, such as between 0.5 and 5.0 wt% of the composition, such as between 0.5 and 4.0 wt% of the composition.
In an advantageous embodiment of the invention, the inorganic divalent cation is provided as an inorganic salt comprising an inorganic anion selected from the group consisting of: chloride, bromide, nitrate, sulfate, bicarbonate, hydrogen phosphate, oxygen, hydroxide, and any combination thereof.
It should be noted that in some embodiments, the inorganic anions may be combined, for example, such that the cation forms a separate salt with two different types of anions. An example may be, for example, magnesium chloride in combination with magnesium bromide.
In an advantageous embodiment of the invention, wherein the inorganic divalent cation is provided as an inorganic salt comprising an inorganic anion selected from the group consisting of: chloride, bromide, sulfate, bicarbonate, and any combination thereof.
In an advantageous embodiment of the invention, wherein the inorganic divalent cation is provided as an inorganic salt comprising an inorganic anion selected from the group consisting of: chloride, bromide, sulfate, and any combination thereof.
In an advantageous embodiment of the invention, wherein the inorganic divalent cation is provided as an inorganic salt comprising an inorganic anion selected from the group consisting of: chloride, bromide, and any combination thereof.
In an advantageous embodiment of the invention, the inorganic anions comprise chloride ions.
In one embodiment of the invention, the inorganic cation is magnesium and/or calcium and the anion comprises chloride.
In one embodiment of the invention, the inorganic anion is chloride.
In one embodiment of the invention, the inorganic cation is magnesium and/or calcium and the anion is chloride.
In an advantageous embodiment of the invention, the inorganic divalent cation is provided as an inorganic salt selected from calcium chloride or magnesium chloride or a combination thereof.
In one embodiment of the invention, the divalent cation is provided as a pharmaceutically acceptable salt.
In one embodiment of the invention, the divalent cation is provided as a pharmaceutically acceptable inorganic salt.
In one embodiment of the invention, the inorganic divalent cation is provided as a hydrated salt.
In one embodiment of the invention, the inorganic divalent cation is provided as a hydrated inorganic salt.
In one embodiment of the invention, the divalent cation is provided as an acceptable salt for the digestive tract.
In one embodiment of the invention, the divalent cation is provided as an inorganic salt acceptable to the digestive tract.
In an advantageous embodiment of the invention, the divalent cation is provided as a water soluble salt having a water solubility of at least 5 grams per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0.
Atmospheric pressure is understood to be a pressure of about 101.3kPa or a pressure in the range of 90 to 110 kPa.
In one embodiment of the invention, the pouch composition comprises an inorganic divalent cation provided as a water-soluble salt, wherein the pouch composition comprises the inorganic divalent cation provided as a water-soluble salt in a molar ratio of between 0.1 and 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 6.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 3.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 2.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 1.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In one embodiment of the invention, the inorganic divalent cation is provided as a water soluble salt in an amount between 0.1 and 15.0% by weight of the composition.
In one embodiment of the invention, the divalent cation is provided as an inorganic, water-soluble salt having a water solubility of at least 5 grams per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0.
In one embodiment of the invention, the inorganic divalent cation is provided as a water soluble salt in an amount of between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 7.0 wt% of the composition, such as between 0.1 and 7.0 wt% of the composition, such as between 0.5 and 5.0 wt% of the composition, such as between 0.5 and 4.0 wt% of the composition.
In one embodiment of the invention, the pouch composition comprises an inorganic divalent cation provided as an inorganic water-soluble salt, wherein the pouch composition comprises the inorganic divalent cation provided as an inorganic water-soluble salt in a molar ratio of between 0.1 and 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 6.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 3.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 2.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 1.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In one embodiment of the invention, the inorganic divalent cation is provided as an inorganic, water-soluble salt in an amount of between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 7.0 wt% of the composition, such as between 0.1 and 7.0 wt% of the composition, such as between 0.5 and 5.0 wt% of the composition, such as between 0.5 and 4.0 wt% of the composition.
"providing" is herein understood to mean that the inorganic cation is added to the composition as a salt.
By providing divalent cations as water-soluble salts, the dissociation of the salts into cations can advantageously be faster and more efficient, whereby relatively fast nicotine release can be achieved.
In an advantageous embodiment of the invention, the pouch composition comprises nicotine in an amount of at least 0.1% by weight of the pouch composition, such as at least 0.2% by weight.
In one embodiment of the invention, the pouch composition comprises nicotine in an amount of 0.1 to 5.0% by weight of the pouch composition, such as 0.2 to 4.0% by weight of the pouch composition, such as 1.0 to 2.0% by weight of the pouch composition.
The pouch composition should have a desired content of nicotine that is capable of providing a desired dose of nicotine to the user while also providing a desired volume of the composition enclosed in the pouch to the user.
In an advantageous embodiment of the invention, the pouch composition comprises a nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition.
It is understood herein that the divalent cations do not form part of the nicotine-ion exchange combination when the pouch composition is prepared. If combined prior to preparing the pouch composition. Pre-combination may cause stability problems because divalent cations may induce premature release of nicotine from the ion exchange resin. This can be particularly problematic when such a combination is incorporated into a pouch composition having a high water content, such as having a water content of at least 15% by weight of the pouch composition.
In one embodiment of the invention, divalent cations are not included in the provided nicotine-ion exchange combinations.
In one embodiment of the invention, the nicotine-ion exchange combination does not comprise divalent cations.
In one embodiment of the invention, the divalent cation is provided as a salt.
In one embodiment of the invention, the pouch composition comprises a nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, such as 1.0 to 15% by weight of the pouch composition, such as 3.0 to 15% by weight of the pouch composition, such as 5.0 to 15% by weight of the pouch composition.
In one embodiment of the invention, the pouch composition comprises a nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, such as 1.0 to 15% by weight of the pouch composition, such as 1.0 to 10% by weight of the pouch composition, such as 3.0 to 10% by weight of the pouch composition.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50% by weight.
In one embodiment of the invention, the nicotine-ion exchange resin combination comprises nicotine complexed with an ion exchange resin, wherein the nicotine comprises an amount between 5 and 50% by weight of the nicotine-ion exchange resin combination.
In one embodiment of the invention, the nicotine-ion exchange resin combination consists of nicotine complexed with an ion exchange resin, wherein nicotine constitutes an amount between 10 and 50% by weight of the nicotine-ion exchange resin combination, such as between 10 and 40% by weight of the nicotine-ion exchange resin combination, such as between 10 and 30% by weight of the nicotine-ion exchange resin combination, such as between 10 and 25% by weight of the nicotine-ion exchange resin combination.
In one embodiment of the invention, the nicotine-ion exchange resin combination comprises free base nicotine admixed with an ion exchange resin, wherein nicotine comprises an amount of between 5 and 50% by weight of the nicotine-ion exchange resin combination.
In one embodiment of the invention, the nicotine-ion exchange resin combination comprises free base nicotine admixed with an ion exchange resin, wherein nicotine constitutes an amount between 5 and 50% by weight of the nicotine-ion exchange resin combination, such as between 10 and 50% by weight of the nicotine-ion exchange resin combination, such as between 20 and 50% by weight of the nicotine-ion exchange resin combination, such as between 25 and 45% by weight of the nicotine-ion exchange resin combination.
In one embodiment of the invention, the nicotine-ion exchange resin combination comprises free base nicotine admixed with an ion exchange resin, wherein nicotine constitutes an amount between 5 and 40% by weight of the nicotine-ion exchange resin combination, such as between 10 and 35% by weight of the nicotine-ion exchange resin combination, such as between 10 and 25% by weight of the nicotine-ion exchange resin combination, such as between 10 and 15% by weight of the nicotine-ion exchange resin combination.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination comprises between 5 and 50% by weight of nicotine and between 10 and 95% by weight of ion exchange resin.
In one embodiment of the invention, the nicotine-ion exchange resin combination comprises between 5 and 50% by weight nicotine and between 10 and 95% by weight ion exchange resin.
In one embodiment of the invention, the nicotine-ion exchange resin combination comprises between 10 and 30% by weight nicotine and between 20 and 90% by weight ion exchange resin.
In one embodiment of the invention, the nicotine-ion exchange resin combination consists of nicotine in an amount between 10 and 30% by weight and ion exchange resin in an amount between 70 and 90% by weight.
In one embodiment of the invention, the nicotine-ion exchange resin combination is substantially free of water.
In one embodiment of the invention, the nicotine-ion exchange resin combination further comprises a C3 sugar alcohol.
In one embodiment, the C3 sugar alcohol may be selected from glycerol, propylene glycol, and any combination thereof.
In one embodiment of the invention, the nicotine-ion exchange resin combination further comprises glycerin.
In one embodiment of the invention, the nicotine-ion exchange resin combination further comprises glycerin in an amount of 0.1 to 50% by weight, such as 5 to 40% by weight, such as 5 to 30% by weight.
In one embodiment of the invention, the nicotine-ion exchange resin combination comprises between 5 and 50% by weight nicotine and between 20 and 75% by weight ion exchange resin.
In one embodiment of the invention, the nicotine-ion exchange resin combination comprises water in an amount of no more than 75 wt%, such as no more than 50 wt%, such as no more than 40 wt%, such as no more than 30 wt%, such as no more than 20 wt%, such as no more than 10 wt%, such as no more than 5 wt%.
In an advantageous embodiment of the invention, the ion exchange resin comprises one or more resins selected from the group consisting of:
(i) Methacrylic weak acid type resin containing carboxylic acid type functional group,
(ii) A copolymer of methacrylic acid and divinylbenzene, said copolymer containing carboxylic acid-based functional groups,
(iii) A strongly acidic type of polystyrene resin containing sulfonic acid-based functional groups,
(iv) A resin of medium acidic type in polystyrene containing phosphoric acid-based functional groups, and
(v) A combination thereof.
In an advantageous embodiment of the invention, the ion exchange resin comprises a polacrilex (polacrilex) resin.
In an advantageous embodiment of the invention, the ion exchange resin is a polyclelin resin.
In one embodiment of the invention, the ion exchange resin is a polyclelin resin.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination comprises nicotine complexed with an ion exchange resin.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination is nicotine complexed with an ion exchange resin.
Thus, in the above embodiments, the nicotine-ion exchange resin combination consists of nicotine complexed with an ion exchange resin.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination comprises free base nicotine mixed with an ion exchange resin.
One advantage of the above embodiments may be to provide sustained release of nicotine. At the same time, the release rate of nicotine is not too slow to give the desired craving relief to the user.
In one embodiment of the invention, the nicotine-ion exchange resin combination is free base nicotine mixed with an ion exchange resin.
In one embodiment of the invention, the pouch composition further comprises nicotine.
In one embodiment of the invention, the pouch composition further comprises nicotine.
In one embodiment of the invention, the pouch composition further comprises nicotine selected from the group consisting of: nicotine salts, nicotine free base, nicotine bound to an ion exchanger such as an ion exchange resin (e.g. nicotine polyclelin resin), nicotine inclusion complex or any non-covalently bound nicotine; nicotine bound to zeolite; nicotine combined with cellulose such as microcrystalline cellulose or starch microspheres, and mixtures thereof.
In an advantageous embodiment of the invention, the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 20-40% by weight of the composition, such as 25-35% by weight of the composition.
In one embodiment of the invention, the pouch composition comprises water in an amount of 15 to 65% by weight of the composition, such as 20 to 65% by weight of the composition, such as 25 to 65% by weight of the composition.
In one embodiment of the invention, the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 15-40% by weight of the composition.
In one embodiment of the invention, the pouch composition comprises water in an amount of 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 15-40% by weight of the composition, such as 15-30% by weight of the composition.
In one embodiment of the invention, the pouch composition comprises water in an amount of 15-40% by weight of the composition.
The water may be added as a separate component to be fully or partially mixed into other components such as the fibers. For example, when nicotine ion exchange resin is added in combination with a mixture of free base nicotine and ion exchange resin and water, a significant amount of water in the final pouch composition can come from the mixture. For example, if the final amount of the pouch composition contains 5% water from the nicotine-ion exchange resin combination, up to one third of the water source in the pouch composition is from the nicotine-ion exchange resin combination.
In an advantageous embodiment of the invention, the pouch composition comprises at least one sugar alcohol.
In one embodiment of the present invention xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol and mixtures thereof are used as the at least one sugar alcohol. The at least one sugar alcohol may further comprise an additional sugar alcohol. As an example embodiment, hydrogenated starch hydrolysates may be used, comprising mixtures of sorbitol, maltitol and other sugar alcohols.
The sugar alcohol may advantageously promote and induce salivation of the pouch composition, thereby achieving dissociation of the inorganic divalent cations and release of nicotine, such as release of nicotine from the ion exchange resin and release of nicotine from the pouch.
Sugar alcohols may advantageously be used to further increase nicotine release from the pouch.
In addition, sugar alcohols can be advantageously used to obtain a desired mouthfeel by increasing salivary secretion and thereby counteract any localized dehydration or mouth dehydration sensation experienced by the pouch user.
Thus, sugar alcohols can be advantageously used in combination with inorganic divalent cations to achieve the desired nicotine release while also achieving the desired taste.
In one embodiment of the invention, the at least one sugar alcohol is selected from sugar alcohols having at least 4 carbon atoms.
In an advantageous embodiment of the invention, the at least one sugar alcohol is selected from xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol and mixtures thereof.
In an advantageous embodiment of the invention, the pouch composition comprises at least two sugar alcohols.
It should be noted that different sugar alcohols may be applied for taste and salivation purposes, wherein the sugar alcohol composition is made of different sugar alcohols having different properties in terms of storage, bacterial growth, processability and/or taste.
In one embodiment of the invention, the at least two sugar alcohols are selected from xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol and mixtures thereof.
In an advantageous embodiment of the invention, the pouch composition comprises sugar alcohol in an amount of at least 1% by weight of the composition, such as at least 2% by weight of the composition, such as at least 5% by weight of the composition, such as at least 10% by weight of the composition, such as at least 15% by weight of the composition.
In an advantageous embodiment of the invention, the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition.
In one embodiment, the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition.
In one embodiment, the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 10 to 70% by weight of the composition, such as 10 to 60% by weight of the composition, such as 15 to 60% by weight of the composition, such as 20 to 50% by weight of the composition.
In an advantageous embodiment of the invention, the pouch composition comprises at least one water insoluble fiber.
In an advantageous embodiment of the invention, the bag composition comprises said water insoluble fiber in an amount of between 5 and 50% by weight of the bag composition, such as 10-45% by weight of the bag composition, such as 15-40% by weight of the bag composition.
In one embodiment of the invention, the pouch composition comprises said water insoluble fiber in an amount of between 5 to 50% by weight of the pouch composition, such as 5-45% by weight of the pouch composition, such as 5-40% by weight of the pouch composition.
In one embodiment of the invention, the pouch composition comprises said water insoluble fiber in an amount of between 5 to 50% by weight of the pouch composition, such as 10-50% by weight of the pouch composition, such as 15-50% by weight of the pouch composition.
One advantage of the above embodiments may be that residues remain even after use of the nicotine pouch comprising the pouch composition. This may give the user of the nicotine bag a pleasant perception, for example due to the similarity to tobacco-containing products.
The water insoluble fiber may advantageously provide a desired mouthfeel throughout the use of the bag.
In an advantageous embodiment of the invention, the water-insoluble fiber is a vegetable fiber.
In an advantageous embodiment of the invention, the water insoluble fiber is selected from the group consisting of wheat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, cellulose fiber, bran fiber, bamboo fiber, powdered cellulose and combinations thereof.
Powdered cellulose within the scope of the present invention is understood to be cellulose produced by processing alpha-cellulose obtained as pulp, such as wood pulp, from a fibrous plant material line.
In one embodiment of the invention, the water insoluble fiber comprises or consists of cereal plant fibers.
In one embodiment of the invention, the water insoluble fiber comprises or consists of fruit and/or vegetable fibers.
In one embodiment of the invention, the water-insoluble composition comprises or consists of water-insoluble fibers selected from the group consisting of: wheat fiber, oat fiber, pea fiber, powdered cellulose, or combinations thereof.
In one embodiment of the invention, the water insoluble fiber is selected from wheat fiber, oat fiber, pea fiber, powdered cellulose or a combination thereof.
In one embodiment of the invention, the water-insoluble composition comprises or consists of water-insoluble fibers selected from the group consisting of: wheat fiber, oat fiber, pea fiber, or combinations thereof.
In one embodiment of the invention, the water insoluble fiber is selected from wheat fiber, oat fiber, pea fiber, or a combination thereof.
In one embodiment of the invention, the water-insoluble composition comprises or consists of water-insoluble fibers selected from the group consisting of: wheat fiber, oat fiber, or combinations thereof.
In one embodiment of the invention, the water insoluble fiber is selected from wheat fiber, oat fiber, or a combination thereof.
In one embodiment of the invention, the water insoluble fiber is powdered cellulose.
Non-limiting examples of useful water insoluble fibers include Vitacel WF 600, vitacel HF 600, vitacel P95, vitacel WF 200, vitacel L00, vitacel Erbsenfaser EF 150, vitacel bamboo fiberbaf, vitacel HF 600, vitacel Cellulose L G, vitacel PF200, vitacel potatofiber KF200, vitacel bamboo fiberhaf BAF40, vitacel Haferfaser/oat fiber HF-401-30US.
Non-limiting examples of powdered cellulose that may be used include Vitacel L00, vitacel Cellulose L G, vitacel LC1000, vitacel L600-20, vitacel L600, and the like.
In one embodiment, the powdered cellulose is not chemically modified. Thus, the powdered cellulose may be cellulose fibers that have not been chemically modified, which do not include, for example, microcrystalline cellulose (MCC).
In an advantageous embodiment of the invention, the water-insoluble fiber has a water binding capacity of at least 200%, such as at least 300%, such as at least 400%.
One advantage of the above embodiments may be the high water binding capacity enabling a bag composition with a high water content.
Furthermore, bags with high water content were found to have desirable texture and mouthfeel while still being able to store the manufactured bags together adjacent, e.g. in cans or the like without adhering together too much resulting in breakage of the bag upon removal.
In addition, the water insoluble fiber having a high water binding capacity may reduce any nicotine exchange caused by divalent cations that occurs before the pouch is used.
Thus, a pouch comprising water-insoluble fibers having a high water binding capacity may advantageously have a reduced Relative Standard Deviation (RSD) of nicotine content.
In an advantageous embodiment of the invention, the nicotine content between a series of at least 10 oral bags comprising said bag composition is kept below 10%, preferably below 8%, more preferably at most 6%, even more preferably at most 4%, most preferably at most 2% Relative Standard Deviation (RSD).
In one embodiment of the invention the nicotine content between a series of at least 10 oral bags comprising said bag composition is maintained at a Relative Standard Deviation (RSD) of 0.1-10%, preferably 0.1-8%, more preferably 0.1-6%, even more preferably 0.1-4%, most preferably 0.1-2%.
In one embodiment of the invention, the water insoluble fiber has a water binding capacity of 300 to 1500%, such as 400 to 1300%.
In one embodiment of the invention, the water insoluble fiber has a water binding capacity of 200% to 1500%, such as 300 to 1300%, such as 200 to 800%, such as 300 to 800%, such as 400 to 600%.
In one embodiment of the invention, the water insoluble fiber has a water binding capacity of 200 to 1500%, such as 300 to 1300%, such as 300 to 900%, such as 300 to 700%, such as 400 to 700%.
In one embodiment of the invention, the water insoluble fiber has a water binding capacity of 200 to 1500%, such as 400 to 1500%, such as 500 to 1200%, such as 500 to 1000%.
In one embodiment of the invention, the water insoluble fiber has a swelling capacity of at least 5.0mL/g, such as 5.0-20 mL/g.
One advantage of the above embodiments is that the amount of water insoluble fiber can be reduced without compromising mouthfeel during use. If a certain amount of water-insoluble fiber is substituted for the water-soluble component, the swelling of the water-insoluble fiber will counteract the dissolution of the water-soluble component during use, and thus the user will not experience any reduction of the bag content during use.
In one embodiment of the invention, the water insoluble fiber is selected from pea fibers, powdered cellulose, and combinations thereof, and wherein the pouch composition comprises a flavoring in an amount of no more than 10% by weight of the pouch composition.
In one embodiment of the invention, the pouch composition comprises water insoluble fiber selected from pea fiber and powdered cellulose or combinations thereof in an amount of 0.01-10% by weight of the pouch composition of the flavoring agent.
In an advantageous embodiment of the invention, the water-insoluble fiber has a density of 50 to 500 g/l, such as 100 to 400 g/l, such as 200 to 300 g/l.
The use of water insoluble fibers having a relatively low bulk density will not only provide a good mouthfeel, but will also provide for an effective release from the pouch due to the fact that the relatively low bulk density promotes effective salivary secretion to dissolve and release the water soluble components of the composition.
In an advantageous embodiment of the invention, the pouch composition comprises a pH adjuster.
In an advantageous embodiment of the invention, the pouch composition comprises a pH adjusting agent in an amount of between 0.01 and 15% by weight of the pouch composition, such as between 0.5 and 10% by weight of the pouch composition, such as between 1 and 10% by weight of the pouch composition, such as between 5 and 10% by weight of the pouch composition.
It may be desirable to obtain a relatively fast nicotine release rate and an efficient uptake/absorption, as this will ensure a fast effect on the user, i.e. craving relief.
Furthermore, having a combination of efficient release and efficient absorption advantageously enables relatively high utilization of the nicotine dose within the pouch. The relatively high utilization of the nicotine dose within the pouch may further provide for a reduction of the necessary nicotine dose of the pouch without compromising the resulting effect. Lower nicotine doses in turn can lead to reduced production costs, as nicotine can be relatively expensive, but can also assist users desiring to reduce their nicotine intake.
In an advantageous embodiment of the invention, the pH adjustor is an alkaline pH adjustor, such as an alkaline buffer.
In an advantageous embodiment of the invention, the pH adjusting agent is a buffer, such as an alkaline buffer.
In one embodiment of the invention, the pH adjuster is water soluble.
In one embodiment of the invention, the pH adjustor has a water solubility of at least 5 grams per 100mL of water measured at 25 degrees Celsius, atmospheric pressure, and pH 7.0.
In one embodiment of the invention, the pouch composition is adapted to give a pH of at least 8.0, such as a pH of at least 9.0, when 2.0 grams of the pouch composition is added to 20ml of 0.02m potassium dihydrogen phosphate buffer (pH adjusted to 7.4).
One advantage of the above embodiments may be that relatively efficient nicotine uptake is facilitated due to the high pH values obtained.
Another advantage of the above embodiments may be that the need for preservatives may be reduced or even eliminated, and low amounts of such preservatives may be used if not absent.
In addition, the high pH values obtained may advantageously provide a tingling sensation in the mouth that may be perceived as a desired mouthfeel, for example due to similarity to tobacco-based pouch products.
In one embodiment of the invention, the pH adjusting agent is selected from acetic acid, adipic acid, citric acid, fumaric acid, glucono-delta-lactone, gluconic acid, lactic acid, malic acid, maleic acid, tartaric acid, succinic acid, propionic acid, ascorbic acid, phosphoric acid, sodium orthophosphate, potassium orthophosphate, calcium orthophosphate, sodium diphosphate, potassium diphosphate, calcium diphosphate, pentasodium triphosphate, pentapotassium triphosphate, sodium polyphosphate, potassium polyphosphate, carbonic acid, sodium carbonate, sodium bicarbonate, potassium carbonate, calcium carbonate, magnesium oxide, or any combination thereof.
In one embodiment of the invention, the pH adjusting agent is selected from acetic acid, adipic acid, citric acid, fumaric acid, glucono-delta-lactone, gluconic acid, lactic acid, malic acid, maleic acid, tartaric acid, succinic acid, propionic acid, ascorbic acid, phosphoric acid, sodium orthophosphate, potassium orthophosphate, sodium diphosphate, potassium diphosphate, pentasodium triphosphate, pentapotassium triphosphate, sodium polyphosphate, potassium polyphosphate, carbonic acid, sodium carbonate, sodium bicarbonate, potassium carbonate, magnesium oxide, or any combination thereof.
In an advantageous embodiment of the invention, the pH adjusting agent is selected from sodium carbonate, sodium bicarbonate, potassium carbonate and magnesium carbonate; potassium bicarbonate; tromethamine; phosphate buffer, amino acid, or any combination thereof.
In one embodiment, the pouch composition comprises an inorganic divalent cation, which may be provided as a water soluble salt, and in addition thereto comprises a pH adjusting agent selected from the group consisting of: sodium carbonate, sodium bicarbonate, potassium carbonate, and magnesium carbonate; potassium bicarbonate; tromethamine; phosphate buffer; amino acids, or any combination thereof.
In one embodiment, the pouch composition comprises an inorganic divalent cation, which may be provided as a water soluble salt, and in addition thereto comprises a pH adjusting agent selected from the group consisting of: sodium carbonate, sodium bicarbonate, potassium carbonate, and magnesium carbonate; potassium bicarbonate; tromethamine; phosphate buffer; or any combination thereof.
In one embodiment, the pouch composition comprises an inorganic divalent cation, which may be provided as a water soluble salt, and in addition thereto comprises a pH adjusting agent selected from the group consisting of: sodium carbonate, sodium bicarbonate, potassium carbonate, and magnesium carbonate; potassium bicarbonate; tromethamine; or any combination thereof.
In this context, the term "tromethamine" refers to (tris (hydroxymethyl) aminomethane), sometimes also referred to as tris buffer.
In the present context, the term "phosphate buffer" refers to alkali metal and alkaline earth metal phosphates such as sodium orthophosphate, potassium orthophosphate, calcium orthophosphate, sodium diphosphate, potassium diphosphate, calcium diphosphate, pentasodium triphosphate, pentapotassium triphosphate, sodium polyphosphate, potassium polyphosphate.
In an advantageous embodiment of the invention, the pH adjusting agent is selected from tromethamine, amino acid and phosphate buffer or any combination thereof.
In an advantageous embodiment of the invention, the pH adjusting agent is selected from tromethamine and phosphate buffer or any combination thereof.
Tromethamine and phosphate buffers have desirable relatively neutral tastes and therefore the use of these pH adjusters may not impair the taste and mouthfeel of the pouch composition.
In an advantageous embodiment of the invention, the pH regulator is selected from tromethamine.
In one embodiment of the invention, the pH adjuster is tromethamine.
In one embodiment of the invention, the pH adjuster comprises tromethamine.
In one embodiment of the invention, the pH adjusting agent is an amino acid.
In one embodiment of the invention, the pH adjuster comprises an amino acid.
In one embodiment of the invention, the pH adjustor is a phosphate buffer.
In one embodiment of the invention, the pH adjuster comprises a phosphate buffer.
In one embodiment of the invention, the pH adjustor is a phosphate buffer selected from the group consisting of: sodium orthophosphate, potassium orthophosphate, calcium orthophosphate, sodium diphosphate, potassium diphosphate, calcium diphosphate, pentasodium triphosphate, pentapotassium triphosphate, sodium polyphosphate, potassium polyphosphate, and combinations thereof.
In one embodiment, the pH adjuster is an alkali metal phosphate buffer.
In one embodiment, the phosphate buffer is an alkali metal phosphate buffer.
In one embodiment, the phosphate buffer is an alkali metal phosphate buffer selected from the group consisting of: sodium orthophosphate, potassium orthophosphate, sodium diphosphate, potassium diphosphate, pentasodium triphosphate, pentapotassium triphosphate, sodium polyphosphate, potassium polyphosphate, and combinations thereof.
In one embodiment, the phosphate buffer is provided as a water-soluble composition.
In one embodiment of the invention, the pH adjuster does not comprise carbonate and/or bicarbonate.
In one embodiment of the invention, the pH adjustor is a non-carbonate and/or non-bicarbonate buffer or a combination thereof.
In one embodiment of the invention, the pouch composition is free of carbonates.
In one embodiment of the invention, the pouch composition comprises a humectant.
In one embodiment, the wetting agent is selected from the following list: glycerol, propylene glycol, alginate, pectin, modified starch, hydroxypropyl cellulose, glyceryl triacetate, polyethylene glycol (PEG), xanthan gum, and combinations thereof.
In one embodiment, the humectant is or comprises the humectant in an amount of from 0.5 to 10%, such as from 0.5 to 5% by weight of the pouch composition, such as 1-3% by weight of the pouch composition.
In one embodiment, the humectant is or comprises an alginate, such as sodium alginate, for example, in an amount of 0.5 to 10%, such as 0.5 to 5% by weight of the pouch composition, such as 1-3% by weight of the pouch composition.
In one embodiment of the invention, the pouch composition is free of alginate.
In one embodiment of the invention, the pouch composition is free of humectants consisting of alginate, pectin, and xanthan gum.
In one embodiment of the invention, the pouch composition is free of humectants selected from the list: glycerol, propylene glycol, alginate, pectin, modified starch, hydroxypropyl cellulose, glyceryl triacetate, polyethylene glycol (PEG), xanthan gum, and combinations thereof.
In one embodiment of the invention, the pouch composition is free of humectants.
In an advantageous embodiment of the invention, the pouch composition is adapted to release at least 30% of nicotine within 10 minutes upon exposure to the in vitro conditions described in example 7A.
In an advantageous embodiment of the invention, the pouch composition is adapted to release at least 25% more nicotine within 5 minutes than a corresponding pouch composition without divalent cations upon exposure to the in vitro conditions described in example 7A.
In an advantageous embodiment of the invention, the pouch composition comprises sodium chloride in an amount of 0.0-3.0% by weight of the pouch composition, such as 0.05-1.0% by weight of the pouch composition, such as 0.1-1.0% by weight of the pouch composition.
Sodium chloride may advantageously be added in small amounts, i.e. 0.0-3.0 wt.%, as a flavour enhancer. The addition of higher amounts of sodium chloride may cause undesirable taste or mouthfeel.
In an advantageous embodiment of the invention, the pouch composition further comprises a preservative.
The preservative may help to keep the pouch composition from undesirable microbial growth.
In an advantageous embodiment of the invention, the pouch composition further comprises a preservative in an amount of 0.05 to 0.5% by weight of the pouch composition, such as 0.1 to 0.2% by weight of the pouch composition.
Non-limiting examples of useful preservatives within the scope of the present invention include sorbic acid (E200) and salts thereof (e.g., sodium sorbate (E201), potassium sorbate (E202), calcium sorbate (E203)), benzoic acid (E210) and salts thereof (e.g., sodium benzoate (E211), potassium benzoate (E212), calcium benzoate (E213)).
In an advantageous embodiment of the invention, the pouch composition comprises less than 0.1% by weight of preservative, such as less than 0.05% by weight of preservative.
Thus, the pouch composition may comprise a preservative in an amount of 0 to 0.1% by weight, such as in an amount of 0 to 0.05% by weight. This includes zero preservative content, i.e., the pouch composition is preservative-free. By obtaining a relatively alkaline environment, in particular by using the free base nicotine, a low or even no preservative use can be achieved.
In an advantageous embodiment of the invention, the pouch composition is preservative-free.
In an advantageous embodiment of the invention, the pouch composition is a non-tobacco pouch composition.
In an advantageous embodiment of the invention, the pouch composition comprises less than 2.0% by weight of tobacco, such as less than 1.0% by weight of tobacco, such as less than 0.5% by weight of tobacco, such as 0.0% by weight of tobacco.
In an advantageous embodiment of the invention, the pouch composition comprises non-tobacco fibers.
In an advantageous embodiment of the invention, the pouch composition is a powdered composition.
The invention also relates to an oral pouch nicotine product comprising a saliva permeable pouch and a pouch composition according to the invention or any embodiment thereof enclosed in said pouch.
In an advantageous embodiment of the invention, the packaged nicotine product comprises nicotine in an amount of 0.5 to 20mg, such as 1.0 to 20mg, such as 5.0 to 15 mg.
In an advantageous embodiment of the invention, the packaged nicotine product comprises nicotine-ion exchange combinations in an amount of 1 to 100mg per bag.
In one embodiment of the invention, the packaged nicotine product comprises a nicotine-ion exchange combination in an amount of 1 to 100mg per bag, such as 10 to 90mg per bag, such as 10 to 80mg per bag, such as 20 to 80mg per bag, such as 30 to 80mg per bag, such as 40 to 80mg per bag, such as 50 to 80mg per bag.
In one embodiment of the invention, the packaged nicotine product comprises a nicotine-ion exchange combination in an amount of 1 to 100mg per bag, such as 10 to 80mg per bag, such as 10 to 60mg per bag, such as 20 to 50mg per bag.
In one embodiment of the invention, the divalent cation is provided as a salt having a water solubility of 5-500 grams per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0, such as 5-350 grams per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 10.0 wt% of the composition, and the inorganic divalent cation is provided as an inorganic salt comprising an inorganic anion selected from the group consisting of chloride, bromide, bicarbonate, sulfate, and any combination thereof.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition, and the divalent cation is provided as a water soluble salt having a water solubility of at least 5 grams per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0.
In one embodiment of the invention, the inorganic divalent cation is provided as an inorganic salt in an amount of between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 10.0 wt% of the composition, and the water soluble salt has a water solubility of at least 5 grams per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition and the pouch composition comprises nicotine in an amount of at least 0.1% by weight of the pouch composition, such as at least 0.2% by weight.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition, the pouch composition comprises nicotine in an amount of at least 0.1% by weight, such as at least 0.2% by weight, of the pouch composition, and the solid oral nicotine formulation comprises the inorganic divalent cation in a molar ratio of at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition, the pouch composition comprising nicotine in an amount of at least 0.1% by weight, such as at least 0.2% by weight, of the pouch composition, and the pouch composition comprises the inorganic divalent cation in a molar ratio of at most 6.5 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 6.0 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 5 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition, and the pouch composition comprises a nicotine-ion exchange combination in an amount of between 0.1 and 20% by weight of the pouch composition.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition, the pouch composition comprises a nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, and the solid oral nicotine formulation comprises the inorganic divalent cation in a molar ratio of at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition, the pouch composition comprises a nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, and the pouch composition comprises the inorganic divalent cation in a molar ratio of at most 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 6.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In one embodiment of the invention, the nicotine-ion exchange resin combination comprises between 5 and 50% by weight nicotine and between 10 and 95% by weight ion exchange resin, and the ion exchange resin is a polycleirine resin.
In one embodiment of the invention, the pouch composition comprises a nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, and the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50% by weight and an ion exchange resin in an amount of between 10 and 95% by weight, and the ion exchange resin is a polyclelin resin.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition, the pouch composition comprises a nicotine-ion exchange combination in an amount of between 0.1 and 20% by weight of the pouch composition, and the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 20-40% by weight of the composition.
In one embodiment, the at least one sugar alcohol is selected from xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol, and mixtures thereof, and the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 10.0 wt% of the composition, the pouch composition comprises a nicotine-ion exchange combination in an amount of between 0.1 and 20 wt% of the pouch composition, the pouch composition comprises a sugar alcohol in an amount of 15-65 wt% of the composition, such as 15-60 wt% of the composition, such as 15-50 wt% of the composition, such as 20-40 wt% of the composition, and the pouch composition comprises a sugar alcohol in an amount of 1 to 80 wt% of the composition, such as 2 to 70 wt% of the composition, such as 5 to 60 wt% of the composition, such as 10 to 50 wt% of the composition, such as 15 to 50 wt% of the composition.
In one embodiment of the invention, the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition, and the pouch composition comprises water insoluble fiber in an amount of between 5 to 50% by weight of the pouch composition, such as 10-45% by weight of the pouch composition, such as 15-40% by weight of the pouch composition.
In one embodiment of the invention, the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition, the pouch composition comprises said water insoluble fiber in an amount of between 5 to 50% by weight of the pouch composition, such as 10-45% by weight of the pouch composition, such as 15-40% by weight of the pouch composition, and the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 20-40% by weight of the composition.
In one embodiment of the invention, the bag composition comprises said water insoluble fiber in an amount of 5 to 50% by weight of the bag composition, such as 10-45% by weight of the bag composition, such as 15-40% by weight of the bag composition, and said water insoluble fiber is selected from the group consisting of wheat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, cellulose fiber, bran fiber, bamboo fiber, powdered cellulose and combinations thereof.
In one embodiment of the invention, the inorganic divalent cation is provided as a salt in an amount of between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 10.0 wt% of the composition, the pouch composition comprises a nicotine-ion exchange combination in an amount of between 0.1 and 20 wt% of the pouch composition, the pouch composition comprises water in an amount of between 15 and 65 wt% of the composition, such as between 15 and 60 wt% of the composition, such as between 15 and 50 wt% of the composition, such as between 20 and 40 wt% of the composition, the pouch composition comprises sugar alcohol in an amount of between 1 and 80 wt% of the composition, such as between 2 and 70 wt% of the composition, such as between 5 and 60 wt% of the composition, such as between 10 and 50 wt% of the composition, such as between 15 and 50 wt% of the pouch composition, and the pouch composition comprises water insoluble fiber in an amount of between 10 and 45 wt% of the pouch composition, such as between 15 and 40 wt% of the pouch composition.
In one embodiment of the invention, the pouch composition comprises a pH adjuster in an amount of between 0.01 and 15% by weight of the pouch composition, such as between 0.5 and 10% by weight of the pouch composition, such as between 1 and 10% by weight of the pouch composition, such as between 5 and 10% by weight of the pouch composition, and the pH adjuster is selected from sodium carbonate, sodium bicarbonate, potassium carbonate and magnesium carbonate; potassium bicarbonate; tromethamine; phosphate buffer, or any combination thereof.
In one embodiment of the invention, the pouch composition comprises a pH adjuster selected from the group consisting of sodium carbonate, sodium bicarbonate, potassium carbonate, and magnesium carbonate in an amount of between 0.01 and 15% by weight of the pouch composition, such as between 0.5 and 10% by weight of the pouch composition, such as between 1 and 10% by weight of the pouch composition, such as between 5 and 10% by weight of the pouch composition; potassium bicarbonate; tromethamine; phosphate buffer, or any combination thereof, and the divalent cation is provided as a water soluble salt having a water solubility of at least 5 grams per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0.
In one embodiment of the invention, the pouch composition comprises a pH adjuster selected from the group consisting of sodium carbonate, sodium bicarbonate, potassium carbonate, and magnesium carbonate in an amount of between 0.01 and 15% by weight of the pouch composition, such as between 0.5 and 10% by weight of the pouch composition, such as between 1 and 10% by weight of the pouch composition, such as between 5 and 10% by weight of the pouch composition; potassium bicarbonate; tromethamine; phosphate buffers, or any combination thereof, and the inorganic divalent cations are provided as inorganic salts comprising inorganic anions selected from chloride, bromide, bicarbonate, sulfate, and any combination thereof.
The present invention also relates to a pouch composition comprising
Nicotine-ion exchange resin combination, and
inorganic multivalent cations.
In an advantageous embodiment of the invention, the multivalent cations are selected from multivalent ions of calcium, magnesium, zinc, aluminum, barium, iron, manganese, copper, lead, cobalt, nickel, such as ca2+, mg2+, zn2+, al3+, ba2+, fe2+, fe3+, fe4+, mn2+, mn4+, cu4+, or any combination thereof.
In one embodiment of the invention, the multivalent cations are selected from ca2+, mg2+, zn2+, ba2+, fe2+, fe3+, fe4+, al3+, mn2+, mn4+, cu4+, and any combination thereof.
In an advantageous embodiment of the invention, the multivalent cations are selected from trivalent cations of aluminum, divalent cations of calcium, magnesium, iron, zinc, and any combination thereof.
In an advantageous embodiment of the invention, the multivalent cations are trivalent cations.
In one embodiment, the trivalent cation is aluminum.
In one embodiment of the invention, the multivalent cation comprises aluminum chloride.
In one embodiment of the invention, the multivalent cations are selected from divalent cations of aluminum chloride, calcium, magnesium, iron, zinc, and any combination thereof.
In an advantageous embodiment of the invention, the multivalent cations are selected from divalent cations of calcium, magnesium, iron, zinc and any combination thereof.
In an advantageous embodiment of the invention, the multivalent cations are selected from divalent cations of calcium, magnesium and any combination thereof.
Detailed Description
As used herein, the term "pouch composition" refers to a composition for use in an oral pouch, i.e., a pouch for oral use. Thus, a pouch composition refers to a composition enclosed within a pouch. In addition, when referring to a composition enclosed within a pouch, the terms "pouch composition", "nicotine pouch composition" and "solid oral nicotine formulation" are used interchangeably.
As used herein, the term "nicotine" refers to nicotine used in the refined/separated substance. In particular, nicotine does not refer to tobacco material having a nicotine content. Thus, when referring to the amount of nicotine (also understood as the nicotine dose), this amount refers to the amount of pure nicotine.
Nicotine also encompasses nicotine that is not obtained from tobacco, commonly referred to as synthetic nicotine.
As used herein, "molar ratio" refers to the ratio of the molar content of the first component divided by the molar content of the second component.
The relative amounts of the first component and the second component may also be presented in terms of equivalents of the first component relative to the second component.
Thus, a pouch comprising divalent cations in a molar ratio of 0.1 relative to the amount of nicotine in the nicotine-ion exchange resin combination may also be present in a pouch comprising 0.1 equivalent of divalent cations relative to the amount of nicotine in the nicotine-ion exchange resin combination, i.e. a pouch comprising 0.1 equivalent of divalent cations and 1 equivalent of nicotine in the nicotine-ion exchange resin combination.
As used herein, the term "free base nicotine" refers to an aprotic form of nicotine and thus excludes nicotine salts or nicotine provided as a complex between nicotine and an ion exchange resin. However, the free base nicotine may be mixed with an amount of ion exchange resin or water soluble composition such as sugar alcohol or water soluble fiber. Although free base nicotine includes both free base nicotine extracted from tobacco and synthetically manufactured free base nicotine, free base nicotine is not provided in the form of tobacco or powdered tobacco. Typically, the free base nicotine is provided as a liquid.
As used herein, the term "bag" is intended to mean a container generally formed from a web of fibrous material that encloses a cavity. The pouch is a pouch designed for the administration of an active ingredient in the oral cavity and is therefore suitable for oral use, it is non-toxic and water insoluble. The fibrous material may, for example, be formed into a woven or nonwoven web or fabric. For example, the pouch may be sealed by bonding two respective webs or fabrics to each other along their edges to form a cavity for nicotine and a water insoluble composition. To release nicotine, the pouch is made water permeable so as to allow saliva from the oral cavity to penetrate the pouch and enter the cavity, where the saliva may come into contact with the nicotine, whereby the nicotine is released from the oral pouch.
As used herein, the term "nicotine-ion exchange resin combination" refers to a combination comprising nicotine complexed with an ion exchange resin and/or free base nicotine mixed with an ion exchange resin.
As used herein, the term "nicotine complexed with an ion exchange resin" refers to nicotine bound to an ion exchange resin.
In the present context, the term "free base nicotine mixed with ion exchange resin" refers to a mixture comprising free base nicotine and ion exchange resin. It should be noted that even though some embodiments comprise a combination of nicotine complexed with an ion exchange resin and nicotine in its free base form in admixture with an ion exchange resin, the term "free base nicotine in admixture with an ion exchange resin" requires the presence of nicotine in its free base form. In some embodiments, the mixture is an aqueous mixture. Mixing the free base nicotine and water with an ion exchange resin, thereby obtaining a mixture comprising both free base nicotine and ion exchange resin. The free base nicotine mixed with the ion exchange resin is referred to as a "premix" in the examples.
As used herein, the term "powder composition" refers to a composition in powder form, i.e., as a particulate material having a relatively small particle size, e.g., a particle size between 1 and 1200 microns. In particular, the powder composition does not mean powdered tobacco.
As used herein, the term "humectant" is understood to be a humectant used to keep the bag moist, i.e. a humectant is added to the bag composition for the purpose of keeping the bag moist. Thus, the term humectant does not refer to substances added for other purposes, hereinafter also hygroscopic substances added for other purposes, such as sugar alcohols, water insoluble fibers and glycerin associated with a nicotine-ion exchange resin combination such as the ion exchange resin in nicotine polacrilex. Examples of humectants include alginate, propylene glycol, hydroxypropyl cellulose, and glycerin. It should be noted that when glycerol is introduced as a humectant, the glycerol is added as free glycerol and is therefore liquid at room temperature. Further examples of humectants include glyceryl triacetate, modified starches, pectins, xanthan gum and the like. The term humectant does not refer to sugar alcohols containing 4 or more carbons. In addition, the term humectant does not refer to fibers such as water insoluble fibers, such as wheat fibers, pea fibers, rice fibers, corn fibers, oat fibers, tomato fibers, barley fibers, rye fibers, beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, cellulose fibers, bran fibers, bamboo fibers, powdered cellulose, and combinations thereof. In addition, the term wetting agent does not include, for example, naCl.
As used herein, the term "water-soluble" refers to relatively high water solubility, for example greater than 5 grams of a water-soluble composition or substance per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0. Unless otherwise indicated, when referring to a "soluble" composition or substance, water-solubility is meant.
As used herein, the term "water insoluble" refers to relatively low water solubility, e.g., less than 0.1 gram of the composition or substance per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0. In reference to "insoluble", unless otherwise indicated, means water insoluble. Thus, a composition or substance that has a water solubility of between 0.1 and 5 grams of the composition or substance per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0 is neither considered water soluble nor water insoluble, but has an intermediate water solubility.
The pouch of the present invention provides nicotine release into the oral cavity. A nicotine release profile comprising both a fast release period and a sustained release period may be obtained.
As used herein, the term "rapid release" or "quick release period" may refer to the first 2 minutes of the nicotine release profile, while the term "sustained release period" refers to the period of time following the release profile until the end of the experiment or end of use.
As used herein, the term "rapid release rate" refers to the nicotine released per minute over the first 2 minutes.
As used herein, the term "effective release" refers to the total release of nicotine during the release or use period of an experiment.
As used herein, the term "dissolution" is a process in which a solid substance enters a solvent (such as oral saliva or water within a bag) to produce a solution.
Typically, the pouch comprises an opening, wherein the characteristic opening size is adapted to the characteristic size of the matrix composition, so as to retain the matrix composition within the pouch prior to use and/or to retain a portion of the matrix composition, such as a water insoluble composition, within the pouch during use.
In order to obtain a bag having a suitable opening size in view of the matrix composition to be used, the material of the bag may be chosen accordingly, including for example woven and/or nonwoven fabrics.
In other words, according to various embodiments, the pouch forms a membrane that allows saliva to pass through and prevents or inhibits the passage of the matrix composition. The film of the pouch may be any suitable material, such as a woven or nonwoven fabric (e.g., cotton, fleece, etc.), a heat sealable nonwoven cellulosic or other polymeric material, such as a synthetic, semi-synthetic or natural polymeric material. One example of a suitable bag material is paper made from pulp and a small amount of wet strength agent. Materials suitable for use must provide a semipermeable membrane layer to prevent the powder or composition from exiting the bag or pouch during use. Suitable materials are also those which have no significant effect on the release of nicotine from the pouch.
The bag composition is filled into the bag and held in the bag by sealing. The ideal pouch is chemically and physically stable, it is pharmaceutically acceptable, it is water insoluble, it is easy to fill with powder and seal, and it provides a semipermeable membrane layer that prevents powder from exiting the pouch but allows saliva and suspended components such as nicotine from the pouch composition dissolved therein or small enough to pass through the pouch.
The bag may be placed in the mouth by the user. Saliva then enters the pouch where nicotine and other components soluble in the saliva begin to dissolve and pass out of the pouch with the saliva into the oral cavity where the nicotine may be absorbed.
According to one embodiment of the invention, the pouch composition may further comprise one or more additives.
In one embodiment of the invention, the additive is selected from bile salts, docetaxel, chelating agents, citrates, cyclodextrins, detergents, enamine derivatives, fatty acids, labrasol, lecithins, phospholipids, synthetic and natural surfactants, nonionic surfactants, cell envelope disturbing compounds, solvents, steroid detergents, chelating agents, solubilizing agents, charge modifying agents, pH adjusting agents, degrading enzyme inhibitors, mucolytic or mucous clearing agents, membrane penetration enhancers, epithelial junction physiology adjusting agents, vasodilators, selective transport enhancers, or any combination thereof. The pH adjuster includes a buffer.
In one embodiment of the present invention, the additive is selected from cetylpyridinium chloride (CPC), benzalkonium chloride, sodium lauryl sulfate, polysorbate 80, polysorbate 20, cetyltrimethylammonium bromide, laureth 9, sodium salicylate, sodium EDTA, aprotinin, sodium taurocholate, saponin, bile salt derivatives, fatty acids, sucrose esters, azone emulsion, dextran sulfate, linoleic acid, labrafil, transcutol, urea, azone, nonionic surfactant, sulfoxide, salicylic acid/PG, POE 23 lauryl ether, methoxysalicylate, dextran sulfate, methanol, ethanol, sodium cholate, sodium taurocholate, lysophosphatidylcholine, alkyl glycoside, polysorbate, sorbitan ester, poloxamer block copolymer, PEG-35 castor oil PEG-hydrogenated castor oil, caprylocaproyl polyethylene glycol-8 glyceride, PEG-8 caprylic/capric glyceride, dioctyl sulfosuccinate, polyethylene lauryl ether, ethoxydiglycol, propylene glycol, mono-di-caprylate, glyceryl monocaprylate, glyceryl fatty acid (C.sub.8-C.sub.18) ethoxylated oleic acid, linoleic acid, caprylic/capric glyceride, glyceryl monooleate, glyceryl monolaurate, caprylic capric triglyceride, ethoxylated nonylphenol, PEG- (8-50) stearate, olive oil PEG-6, esters, triolein PEG-6 ester, lecithin, d-alpha tocopheryl polyethylene glycol 1,000 succinate, citric acid, sodium citrate, BRIJ, sodium laurate, 5-methoxysalicylic acid, bile salts, acetylsalicylate, ZOT, docosahexaenoic acid, alkyl glycoside, sodium glycocholate (GC-Na), sodium taurocholate (TC-Na), EDTA, choline salicylate, sodium caprate (Cap-Na), N-lauryl- β -D-maltopyranoside (LM), diethyl maleate, labrasol, sodium salicylate, menthol, alkali metal alkyl sulfate, sodium dodecyl sulfate, glycerol, cholic acid, lecithin, phosphatidylcholine, phosphatidylserine, sphingomyelin, phosphatidylethanolamine, cephalin, lysolecithin, hyaluronic acid: alkali metal salts, sodium, alkaline earth metals and aluminum, octylphenoxy polyethoxy ethanol, glycolic acid, lactic acid, chamomile extract, cucumber extract, borage oil, evening primrose oil, polyglycerol, lysine, polylysine, triolein, monoolein, monolaurate, polydonol alkyl ether, chenodeoxycholate, deoxycholate, glycocholic acid, taurocholate, glycodeoxycholic acid, taurodeoxycholic acid, sodium glycocholate, phosphatidylcholine, phosphatidylserine, sphingomyelin, phosphatidylethanolamine, cephalin, lysolecithin, alkali metal hyaluronate, chitosan, poly-L-arginine, alkyl glucosides, sugar alkyl esters Fusarium acid derivatives, sodium Taurinate (STDHF), didecanoyl L-alpha-phosphatidylcholine (DDPC), nitroglycerin, sodium nitroprusside, NOC5[3- (2-hydroxy-1- (methyl-ethyl) -2-nitrosohydrazino) -1-propylamine ], NOC12[ N-ethyl-2- (1-ethyl-hydroxy-2-nitrosohydrazino) -ethylamine, SNAP [ S-nitroso-N-acetyl-DL-penicillamine, NORI, NOR4, deacylated methyl sulfoxide (deacylmethyl sulfoxide), azone, salicylamide, glyceryl-1, 3-diacetoacetate, 1, 2-isopropylideneglycerin-3-acetoacetate), amino acid salt, monoaminocarboxylic acid, glycine, alanine, phenylalanine, proline, hydroxyproline, hydroxyamino acid, amino acid, serine, acidic amino acid, aspartic acid, glutamic acid, basic amino acid, lysine, N-acetylamino acid, N-acetylalanine, N-acetylphenylalanine, TM-acetylserine, N-acetylglycine, N-acetyllysine, N-acetylglutamic acid, N-acetylproline, N-acetylhydroxyproline, lactic acid, malic acid and citric acid and alkali metal salts thereof, pyrrolidone carboxylic acid, alkylpyrrolidone carboxylic acid ester, N-alkylpyrrolidone, proline acyl ester, sodium lauryl phosphate, sodium lauryl sulfate, sodium oleyl phosphate, sodium myristyl sulfate, polyoxyethylene alkyl ether, polyoxyethylene alkyl ester, caproic acid, alkyl sugar, fusidic acid, polyethylene glycol, cetyl alcohol, polyvinylpyrrolidone, polyvinyl alcohol, lanolin alcohol, sorbitan monooleate, ethylene glycol tetraacetic acid, cholic acid-taurine conjugate, cholanic acid and salts, cyclodextrins (β), hydroxypropyl- β -cyclodextrin, sulfobutyl ether- β -cyclodextrin, chitosan glutamate, chitosan acetate, chitosan hydrochloride, chitosan hydrogen lactate (chitosan hydrolactate), 1-O-alkyl-2-hydroxy-sn-glycerol-3-phosphorylcholine, 3-O-alkyl-2-acetyl-sn-glycerol-1-phosphorylcholine, 1-O-alkyl-2-O-acetyl-sn-glycerol-3-phosphate (N, n, N-trimethyl) hexanolamine, propylene glycol, tetradecyl maltoside (TDM), sucrose decanoate.
As used herein, the term "pH adjuster" refers to an agent that actively adjusts and regulates the pH of a solution to which they have been added or to which they are to be added. Thus, the pH adjuster may be an acid and a base, including an acidic buffer and a basic buffer. On the other hand, pH adjusters do not include substances and compositions that affect pH by dilution alone. In addition, the pH adjuster does not include, for example, a flavoring agent, a filler, and the like.
In one embodiment of the invention, the pH adjusting agent is selected from acetic acid, adipic acid, citric acid, fumaric acid, glucono-delta-lactone, gluconic acid, lactic acid, malic acid, maleic acid, tartaric acid, succinic acid, propionic acid, ascorbic acid, phosphoric acid, sodium orthophosphate, potassium orthophosphate, calcium orthophosphate, sodium diphosphate, potassium diphosphate, calcium diphosphate, pentasodium triphosphate, pentapotassium triphosphate, sodium polyphosphate, potassium polyphosphate, carbonic acid, sodium carbonate, sodium bicarbonate, potassium carbonate, calcium carbonate, magnesium oxide, tromethamine, phosphate buffer, amino acid, or any combination thereof.
According to various embodiments of the present invention, one or more sugar alcohols may be contained in the pouch as part of the pouch composition, such as a carrier or part thereof or as a sweetener. Suitable sugar alcohols include sugar alcohols selected from the group consisting of: sorbitol, erythritol, xylitol, lactitol, maltitol, mannitol, hydrogenated starch hydrolysates, isomalt or any combination thereof.
In one embodiment of the invention, the pouch composition comprises a high intensity sweetener.
Preferred high intensity sweeteners include, but are not limited to, sucralose, aspartame, salts of acesulfame such as acesulfame potassium, alitame, saccharin and salts thereof, cyclamic acid and salts thereof, glycyrrhizin, dihydrochalcones, thaumatin, monellin (monellin), stevioside, and the like, alone or in combination.
In one embodiment of the invention, the pouch composition comprises a bulk sweetener comprising sugar and/or sugarless components.
In one embodiment of the invention, the pouch composition comprises bulk sweetener in an amount of 1.0 to about 80% by weight of the pouch composition, more typically 5 to about 70% by weight of the pouch composition, more typically 10 to 60% by weight of the pouch composition, or 10-50% by weight of the pouch composition. Bulk sweeteners may act as both sweetener and humectant. In some embodiments, the introduction of certain ingredients may further limit the approximate amount of bulk sweetener.
Sweeteners generally support the flavor profile of the pouch composition.
Sugar sweeteners generally include, but are not limited to, sugar-containing components commonly known in the art of sachets, such as sucrose, dextrose, maltose, sucrose, lactose, sorbose, dextrin, trehalose, D-tagatose, dry invert sugar, fructose, levulose, galactose, corn syrup solids, glucose syrup, hydrogenated glucose syrup, and the like, alone or in combination.
The sweetener may be used in combination with a sugarless sweetener. Generally, sugarless sweeteners include components having sweet taste characteristics but free of commonly known sugars and include, but are not limited to, sugar alcohols such as sorbitol, mannitol, xylitol, hydrogenated starch hydrolysates, maltitol, isomalt, erythritol, lactitol, and the like, alone or in combination.
As used herein, the term "flavor" is understood to have its ordinary meaning in the art. Flavoring agents include liquid and powdered flavoring agents. Thus, the flavoring agent does not of course include sweeteners (such as sugars, sugar alcohols and high intensity sweeteners) or acids that provide pure acidity/acidity, nor compounds that provide pure salty (e.g., naCl) or bitter taste. Flavor enhancers include substances that provide only salty, bitter, or sour tastes. Flavor enhancers thus include, for example, naCl, citric acid, ammonium chloride, and the like.
The flavoring agent may be a natural or synthetic flavoring agent.
In one embodiment of the invention, the pouch composition comprises a flavoring agent. The flavoring agent may generally be present in an amount of between 0.01 and 15% by weight of the total composition of the pouch, such as between 0.01 and 5% by weight of the total composition.
Non-exhaustive examples of flavoring agents suitable for use in embodiments of the present invention are coconut, coffee, chocolate, vanilla, grape fruit, orange, lime, menthol, licorice, caramel, honey, peanut, walnut, cashew, hazelnut, almond, pineapple, strawberry, raspberry, tropical fruit, cherry, cinnamon, peppermint, wintergreen, spearmint, eucalyptus and peppermint fruit essential oils, such as from apple, pear, peach, strawberry, apricot, raspberry, cherry, pineapple and plum essential oils. The essential oil comprises peppermint, spearmint, menthol, eucalyptus, clove oil, bay oil, pimpinella, thyme, cedar leaf oil, nutmeg, and oils of the above fruits.
In various embodiments of the present invention, the pouch composition comprises a composition modifier. Composition modifiers may be added to tailor the properties of the bag composition and/or portions thereof, such as flowability, texture, uniformity, etc.
According to various embodiments, the composition modifier may be selected from the group consisting of metal stearates, modified calcium carbonate, hydrogenated vegetable oils, partially hydrogenated vegetable oils, polyethylene glycols, polyoxyethylene monostearate, animal fats, silicates, silicate dioxide, talc, magnesium stearate, calcium stearate, fumed silica, powdered hydrogenated cottonseed oil, hydrogenated vegetable oils, hydrogenated soybean oil, emulsifiers, triglycerides and mixtures thereof. In particular, metal stearates such as magnesium stearate may be advantageous.
The composition modifier may be added to the pouch composition in various ways.
For example, the composition modifier may be added as a full powder mixture during the last few minutes of final mixing.
Alternatively, the composition modifier may be added after the granulation step of granulating the premix.
Composition modifiers, such as magnesium stearate, may have a sealing effect and may be used to control nicotine release and pouch solubility.
According to one embodiment of the invention, the pouch composition comprises polyvinylpyrrolidone (PVP). The pouch composition may also be free of PVP.
One advantage of the above embodiments may be that a more uniform composition may be obtained.
Examples
Example 1A-preparation of a pouch designed for administration of nicotine
The material of the bag is a heat sealable nonwoven cellulose, such as a long fiber paper. Bags other than in the form of nonwoven cellulosic fabrics may also be used in accordance with the present invention.
The powder is filled into the bag and held in the bag by sealing.
Example 1B-preparation of a pouch designed for administration of nicotine
The material of the bag is made of rayon fibers such as rayon staple fibers from the viscose process. The bag film is heat sealed along its edges except for an opening in one end into the cavity formed by the bag film.
The powder is filled into the bag and held in the bag by sealing.
Example 2: preparation of nicotine premix
Water was charged into a 60 liter planetary Bear Varimixer mixer and nicotine was weighed and added. The mixer was stirred at low speed for 1 minute at ambient temperature. Then the ion exchange resin is weighedIRP64 is added to the mixer. The mixer was turned off and stirred at high speed for 5 minutes, opened and scraped off if necessary. Finally, the mixer was stirred at high speed for a further 5 minutes. The total treatment time was 20 minutes.
Thus, a mixture of nicotine and cation exchange resin was produced from the constituents set forth in the following table.
Premix I:
composition of components | Quantity (kg) | Quantity (%) |
Nicotine | 1.0 | 5.7 |
Water and its preparation method | 12.5 | 71.4 |
Resin composition | 4.0 | 22.9 |
Totals to | 17.5 | 100.0 |
Table 1. Ingredients used to make nicotine premix I (5.7% nicotine). % of water in the resulting nicotine-resin composition: 71.4
Premix II:
composition of components | Quantity (kg) | Quantity (%) |
Nicotine | 1.08 | 13.2 |
Water and its preparation method | 2.80 | 34.1 |
Resin composition | 4.32 | 52.7 |
Totals to | 8.20 | 100.0 |
Table 2. Ingredients used to make nicotine premix II (13.2% nicotine).
% of water in the resulting nicotine-resin composition: 34.1.
premix III:
composition of components | Quantity (kg) | Quantity (%) |
Nicotine | 1.08 | 18.5 |
Water and its preparation method | 0.44 | 7.5 |
Resin composition | 4.32 | 74.0 |
Totals to | 5.84 | 100.0 |
Table 3. Ingredients used to make nicotine premix III (18.5% nicotine). % of water in the resulting nicotine-resin composition: 7.5.
Premix IV:
composition of components | Quantity (kg) | Quantity (%) |
Nicotine | 1.08 | 10.0 |
Water and its preparation method | 5.40 | 50.0 |
Resin composition | 4.32 | 40.0 |
Totals to | 10.8 | 100.0 |
Table 4. Ingredients used to make nicotine premix IV (10% nicotine). % of water in the resulting nicotine-resin composition: 50.0.
premix V:
composition of components | Quantity (kg) | Quantity (%) |
Nicotine | 1.78 | 20.0 |
Water and its preparation method | 2.80 | 31.5 |
Resin composition | 4.32 | 48.5 |
Totals to | 8.90 | 100.0 |
Table 5. Ingredients used to make nicotine premix V (20% nicotine). % of water in the resulting nicotine-resin composition: 31.5.
premix VI:
table 6. Ingredients used to make nicotine premix VI (30% nicotine). % of water in the resulting nicotine-resin composition: 27.5.
premix VII
Composition of components | Quantity (kg) | Quantity (%) |
Nicotine | 3.83 | 35.0 |
Water and its preparation method | 2.80 | 25.6 |
Resin composition | 4.32 | 39.4 |
Totals to | 10.95 | 100.0 |
Table 7. Ingredients used to make nicotine premix VII (35% nicotine). % of water in the resulting nicotine-resin composition: 25.6.
premix VIII:
composition of components | Quantity (kg) | Quantity (%) |
Nicotine | 5.15 | 42.0 |
Water and its preparation method | 2.80 | 22.8 |
Resin composition | 4.32 | 35.2 |
Totals to | 12.27 | 100.0 |
Table 8. Ingredients used to make nicotine premix VIII (42% nicotine). % of water in the resulting nicotine-resin composition: 22.8.
example 3: preparation of bag compositions
Bags containing the powdered compositions as listed in tables 9-21 were prepared. Bags were prepared as follows.
The fibers and water were mixed for 5 minutes using a planetary Bear Varimixer. Then, the following ingredients were subsequently added with continuous mixing: first the nicotine-ion exchange combination (NPR or premix) (2 minutes of mixing), then the remaining ingredients (2 minutes of mixing) except for the liquid flavor and glidant (if any), then the liquid flavor (if any) (1 minute of mixing), then the glidant (if any) (1 minute of mixing). The total mixing time was 9-11 minutes.
Example 4: preparation of filled bags
The final bag composition was filled into bags (target fill weight 500mg of powder per bag). The pouch material of example 1A or 1B may be used. The powder is filled into the bag and held in the bag by sealing.
Example 5A: bag(s)
Bag compositions were prepared from the ingredients in table 9 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 9: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5B:
bag compositions were prepared from the ingredients in table 10 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 10: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
* Corresponds to 1 equivalent of NaCl relative to nicotine in the nicotine ion exchange combination.
* Corresponds to 10 equivalents of NaCl relative to nicotine in the nicotine ion exchange combination.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5C:
bag compositions were prepared from the ingredients in table 11 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 11: a pouch composition.
* The inorganic cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* The multivalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: total 500mg.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5D:
bag compositions were prepared from the ingredients in table 12 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 12: a pouch composition.
* The inorganic cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* The multivalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: total 500mg.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5E:
bag compositions were prepared from the ingredients in table 13 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 13: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5F:
bag compositions were prepared from the ingredients in table 14 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 14: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5G:
bag compositions were prepared from the ingredients in table 15 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 15: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5H:
bag compositions were prepared from the ingredients in table 16 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 16: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitacel 600WF plus" or "Vitacel 200WF".
Powdered cellulose, trade name "Vitacel L00" or "Vitacel L700G".
Oat fiber, trade name "Vitacel HF 600".
Pea fiber, trade name "Vitacel EF150".
Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, powdered cellulose, cellulose fiber, apple fiber, cocoa fiber, bamboo fiber, bran fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5I:
bag compositions were prepared from the ingredients in table 17 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 17: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitacel 600WF plus" or "Vitacel 200WF".
Powdered cellulose, trade name "Vitacel L00" or "Vitacel L700G".
Oat fiber, trade name "Vitacel HF 600".
Pea fiber, trade name "Vitacel EF150".
Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, powdered cellulose, cellulose fiber, apple fiber, cocoa fiber, bamboo fiber, bran fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5J:
bag compositions were prepared from the ingredients in table 18 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 18: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5K:
bag compositions were prepared from the ingredients in table 19 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 19: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5L:
bag compositions were prepared from the ingredients in table 20 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 20: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g (16 mg/g for samples P116, P117 and C12).
Wheat fiber, trade name "Vitace 600WF plus". Powdered cellulose, trade name "powdered cellulose L700G". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 5M:
bag compositions were prepared from the ingredients in table 21 using the preparation method described in example 3.
The bag composition was filled into bags as described in example 4 (using the bag material of example 1A, but 1B could also be applied).
Table 21: a pouch composition.
* The inorganic divalent cations are presented in equivalent numbers relative to nicotine in the nicotine ion exchange combination.
* Divalent cations may be provided as hydrated salts such as dihydrate, tetrahydrate, hexahydrate, etc. The weight% in the table is based on the non-hydrated salt.
Bag contents: in total 500mg, i.e. a nicotine concentration of 19.2mg/g.
Wheat fiber, trade name "Vitace 600WF plus". Other fibers such as water insoluble plant fibers, such as oat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, powdered cellulose, bran fiber, bamboo fiber, and cellulose fiber may also be used.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may be used in combination with or as an alternative to sodium alginate, glycerin, or HPC.
Sodium carbonate was used as alkaline buffer. Other buffers as described herein may also be used in combination with or in place of sodium carbonate.
For example, mixtures of menthol and peppermint may be used as flavoring agents. Of course, other flavors as described herein may also be used in combination with or in place of menthol and/or peppermint. The flavoring may be liquid or flavored or a combination, i.e., liquid flavoring and powdered flavoring are added.
As one example, acesulfame potassium and/or sucralose may be used as high intensity sweeteners. Other useful high intensity sweeteners described herein may be used in combination with or in place of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may be used in combination with or in place of potassium sorbate.
Silica is used as a glidant. Other possible glidants include, for example, magnesium stearate, starch and talc.
Example 6A: release experiments and different salts.
By adding a certain amount of NPR (16%) and a different number of equivalents of CaCl to 900mL of water 2 To perform a release experiment (corresponding to a nicotine concentration of 28 mg/L). CaCl (CaCl) 2 Is relative to nicotine. The temperature of the water was 25 degrees celsius throughout the experiment and stirring at 100rpm was applied throughout the experiment. The pH was measured at the beginning and end of the experiment. At the beginning and end of the experiment, the pH was below 7.0 in all experiments.
Relatively low nicotine concentrations are used to reduce the effect of equilibrium on the release rate and effective release of nicotine from the ion exchange resin.
Samples were taken at various time points and analyzed for nicotine content using standard HPLC. Results are presented as a percentage of nicotine released.
Table 22: nicotine release over time in the presence of different salts and different equivalent numbers of cations.
Evaluation: the results indicate that CaCl 2 The presence of (2) significantly increases the release of nicotine from NPR. Increasing CaCl 2 Resulting in an increased release of nicotine. CaCl (CaCl) 2 The presence of (a) both increases the initial release rate and appears to increase the effective release of nicotine.
Furthermore, the results show that NaCl has a much lower effect on nicotine release, and therefore a large amount of NaCl is required to achieve the same effect as in the presence of e.g. 1 equivalent CaCl 2 Is equivalent to nicotine release.
Example 6B: using NPR and CaCl of varying equivalent numbers 2 Release experiments of (a).
By adding NPR (16%) and CaCl of different equivalent numbers to a volume of water 2 To perform a release experiment (corresponding to a nicotine concentration of 28 mg/L). CaCl (CaCl) 2 Is relative to nicotine. The temperature of the water was 25 degrees celsius throughout the experiment and stirring at 100rpm was applied throughout the experiment. The pH was measured at the beginning and end of the experiment. At the beginning and end of the experiment, the pH was below 7.0 in all experiments.
Relatively low nicotine concentrations are used to reduce the effect of equilibrium on the release rate and effective release of nicotine from the ion exchange resin.
Samples were taken at various time points and analyzed for nicotine content using standard HPLC. Results are presented as a percentage of nicotine released.
Table 23: showing the presence of different equivalent numbers of CaCl 2 The percentage of nicotine released from NPR at different time points.
Evaluation: the results indicate that CaCl 2 The presence of (2) significantly increases the release of nicotine from NPR. Increasing CaCl 2 Resulting in an increased release of nicotine. CaCl (CaCl) 2 The presence of (a) both increases the initial release rate and appears to increase the effective release of nicotine.
Example 6C: using NPR and MgCl of different equivalent numbers 2 Release experiments of (a).
By adding NPR (16%) and MgCl with different equivalent numbers to a volume of water 2 To perform a release experiment (corresponding to a nicotine concentration of 28 mg/L). MgCl 2 Is relative to nicotine. The temperature of the water was 25 degrees celsius throughout the experiment and stirring at 100rpm was applied throughout the experiment. The pH was measured at the beginning and end of the experiment. At the beginning and end of the experiment, the pH was below 7.0 in all experiments.
Relatively low nicotine concentrations are used to reduce the effect of equilibrium on the release rate and effective release of nicotine from the ion exchange resin.
Samples were taken at various time points and analyzed for nicotine content using standard HPLC. Results are presented as a percentage of nicotine released.
Table 24: showing the presence of MgCl in different equivalent numbers 2 The percentage of nicotine released from NPR at different time points.
Evaluation: the results show that MgCl 2 The presence of (2) significantly increases the release of nicotine from NPR. Increasing MgCl 2 Resulting in an increased release of nicotine. MgCl 2 The presence of (a) both increases the initial release rate and appears to increase the effective release of nicotine. The results were comparable to those presented in example 6B.
Example 6D: using 1 equivalent of CaCl 2 And release experiments of nicotine premixes with different nicotine content.
By adding CaCl with different nicotine content and 1 equivalent to a volume of water 2 The release experiments were performed whereby a corresponding nicotine concentration of 28mg/L was obtained. CaCl (CaCl) 2 Is relative to nicotine. The temperature of the water was 25 degrees celsius throughout the experiment and 150 degrees celsius was applied throughout the experimentStirring at rpm. The pH was measured at the beginning and end of the experiment. At the beginning and end of the experiment, the pH was below 7.0 in all experiments.
Relatively low nicotine concentrations are used to reduce the effect of equilibrium on the release rate and effective release of nicotine from the ion exchange resin.
Samples were taken at various time points and analyzed for nicotine content using standard HPLC. Results are presented as a percentage of nicotine released.
Table 25: showing the presence of 1 equivalent of MgCl 2 The percentage of nicotine released from the nicotine premix at different time points.
Evaluation: the results indicate that CaCl 2 The presence of (2) significantly increases the release of nicotine from the premix. CaCl (CaCl) 2 The presence of (a) both increases the initial release rate and appears to increase the effective release of nicotine. Furthermore, the results show that increasing the nicotine content of the premix also increases the nicotine release.
Example 6E: 1 equivalent of AlCl is used 3 Release experiments of (a).
By adding NPR (16%) and 1 equivalent of AlCl to a volume of water 3 To perform a release experiment (corresponding to a nicotine concentration of 28 mg/L). The number of equivalents is relative to nicotine. The temperature of the water was 25 degrees celsius throughout the experiment and 150rpm agitation was applied throughout the experiment. The pH was measured at the beginning and end of the experiment. At the beginning and end of the experiment, the pH was below 7.0 in all experiments.
Relatively low nicotine concentrations are used to reduce the effect of equilibrium on the release rate and effective release of nicotine from the ion exchange resin.
Samples were taken at various time points and analyzed for nicotine content using standard HPLC. Results are presented as a percentage of nicotine released.
Table 24: showing the presence of 1 equivalent of AlCl 3 The percentage of nicotine released from NPR at different time points.
Evaluation: the results show 1 equivalent of AlCl 3 The presence of (2) significantly increases the release of nicotine from NPR. AlCl 3 The presence of (a) both increases the initial release rate and appears to increase the effective release of nicotine.
Example 7A: bag release test (in vitro)
The release properties of the pouches were tested in vitro experiments.
The reaction tube, approximately 2cm in diameter, containing 10mL of 0.02M potassium dihydrogen phosphate buffer (pH adjusted to 7.4) was warmed to 37 degrees Celsius. One reaction tube was used at each time point.
The bag was immersed in the buffer of the first reaction tube using tweezers. After the indicated period of time, the bag was gripped with forceps and gently vortexed in buffer, then removed from the first reaction tube and added to the next reaction tube, which represents the next time point. The procedure was repeated until the desired number of time points were tested.
The entire release experiment was performed at 37 degrees celsius. No stirring or shaking was applied during the release experiment.
The amount of nicotine released was determined by analyzing buffer samples at different time points using standard HPLC.
Example 8A: release test on bags
The release experiments were performed as described in example 7A.
Table 27A: showing the presence of different equivalent numbers of CaCl 2 Is the case of (1)The percentage of nicotine released from the nicotine pouch at different time points.
Table 27B: showing the presence of different equivalent numbers of CaCl 2 The percentage of nicotine released from the nicotine pouch at different time points.
Evaluation: p110 and P113 were compared to C10 and C11, respectively, and the results showed CaCl 2 Is present to increase the release of nicotine from the pouch. This was also confirmed by comparison of P116 with C12. CaCl (CaCl) 2 The presence of (a) both increases the initial release rate and appears to increase the effective release of nicotine. Comparing P40 with P42 and P116 with P117, confirming the increase in CaCl in the bag 2 Also increasing the release of nicotine from the pouch. In addition, it should be noted that the desired improved release results have been demonstrated with various formulations comprising different fibers (here wheat fiber and powdered cellulose).
Furthermore, comparing P40 with P43, P42 with P45 and P110 with P113, the results indicate that increasing the nicotine content of the premix also increases the release of nicotine from the pouch.
Finally, it should be pointed out that, in order to obtain and never contain only 0.75 equivalent CaCl 2 The equivalent release obtained for the bags of (a) will require a much higher amount of NaCl, where at least 2.9 equivalents of NaCl are required to achieve a CaCl equivalent of 0.75 2 Comparable release (see C4, C5, P40 and P43).
Example 9A: and (5) evaluating by a user.
The resulting pouches of the present invention were evaluated and found to be highly suitable as delivery vehicles for nicotine as they provide good nicotine release while being pleasant to the user, e.g. in terms of desired mouthfeel such as wet and plastic structure and desired taste.
Example 9B: and (5) evaluating by a user.
The pouch products P03, P44 and P117 were evaluated in terms of nicotine perception effect and mouthfeel.
The nicotine perception effect and mouthfeel were evaluated as follows.
Nicotine perception and mouthfeel were evaluated by a test panel consisting of 4 trained evaluators. Each evaluator evaluates all samples twice. The average evaluation is estimated.
All four evaluators evaluated that the pouch products P03, P44 and P117 were fast acting and had a high nicotine perception effect. In addition, all four evaluators rated the bag product to have the desired mouthfeel, i.e., the bag was found to be moist and to have the desired taste.
Bags P08 and P127 were similarly evaluated. All four evaluators evaluated that the bags were fast acting and had a high perceived effect of nicotine. However, these bags were found to provide a less desirable mouthfeel, which were perceived as somewhat dry, adhering to the oral mucosa and/or having an unpleasant or less desirable taste, i.e. too salty.
Pouches comparable to P127 but containing higher amounts of flavoring, i.e., P128 and P129, were also evaluated. Although their flavor levels increased compared to P127, these pouches were also perceived as dry and adhered to the oral mucosa. Furthermore, it was found that the taste of these bags was less desirable because salty taste notes were still perceived and the flavor profile was perceived as unbalanced.
These observations indicate that the less desirable mouthfeel and taste effects associated with high levels of inorganic divalent cations cannot be offset by increasing the level of flavoring in the pouch composition. That is, simply masking the taste by means of high levels of flavoring agents does not counteract the adverse effects at high levels of inorganic divalent cations.
Claims (63)
1. A pouch composition comprising
A nicotine-ion exchange resin combination, wherein,
water in an amount of at least 15% by weight of the pouch composition, and
inorganic divalent cations.
2. The pouch composition of claim 1, wherein the pouch composition comprises inorganic divalent cations in a molar ratio of at least 0.1 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.25 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
3. A pouch composition according to claim 1 or 2, wherein the pouch composition comprises inorganic divalent cations in a molar ratio of at most 6.5 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 6 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 5 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 with respect to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 with respect to the amount of nicotine in the nicotine-ion exchange resin combination.
4. A pouch composition according to any of claims 1-3, wherein the inorganic divalent cation is selected from divalent cations of calcium, magnesium, iron, zinc, and any combination thereof.
5. The pouch composition of any of claims 1-4, wherein the inorganic divalent cation is selected from divalent cations of calcium and magnesium.
6. The pouch composition of any of claims 1-5, wherein the inorganic divalent cation is provided as a salt comprising an anion selected from the group consisting of: carboxylate, such as acetate, lactate, oxalate, propionate or levulinate; an organic sulfonate group; organic sulfate radicals; an organic phosphate group; chloride, bromide, nitrate, sulfate, hydrogen phosphate, oxygen ions, and any combination thereof.
7. The pouch composition of any of claims 1-6, wherein the inorganic divalent cation is provided as an inorganic salt.
8. The pouch composition of any of claims 1-7, wherein the inorganic divalent cation is provided as a salt in an amount between 0.1 and 15.0 wt% of the composition, such as between 0.1 and 10.0 wt% of the composition, such as between 0.5 and 10.0 wt% of the composition.
9. The pouch composition according to any one of claims 1-8, wherein the inorganic divalent cation is provided as an inorganic salt comprising an inorganic anion selected from the group consisting of: chloride, bromide, nitrate, sulfate, bicarbonate, hydrogen phosphate, oxygen, hydroxide, and any combination thereof.
10. The pouch composition according to any one of claims 1-9, wherein the inorganic divalent cation is provided as an inorganic salt comprising an inorganic anion selected from the group consisting of: chloride, bromide, bicarbonate, sulfate, and any combination thereof.
11. The pouch composition according to any one of claims 1-10, wherein the inorganic divalent cation is provided as an inorganic salt comprising an inorganic anion selected from the group consisting of: chloride, bromide, and any combination thereof.
12. The pouch composition of any of claims 1-11, wherein the inorganic anion comprises chloride ions.
13. The pouch composition according to any of claims 1-12, wherein the inorganic divalent cation is provided as an inorganic salt selected from calcium chloride or magnesium chloride or a combination thereof.
14. The pouch composition of any of claims 1-13, wherein the divalent cation is provided as a water soluble salt having a water solubility of at least 5 grams per 100mL of water measured at 25 degrees celsius, atmospheric pressure, and pH 7.0.
15. The pouch composition of any of claims 1-14, wherein the pouch composition comprises nicotine in an amount of at least 0.1% by weight of the pouch composition, such as at least 0.2% by weight.
16. The pouch composition of any of claims 1-15, wherein the pouch composition comprises a nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition.
17. The pouch composition of any of claims 1-16, wherein the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50% by weight.
18. The pouch composition of any of claims 1-17, wherein the nicotine-ion exchange resin combination comprises between 5 and 50% nicotine by weight and between 10 and 95% ion exchange resin by weight.
19. The pouch composition of any of claims 1-18, wherein the ion exchange resin comprises one or more resins selected from the group consisting of:
(i) Methacrylic weak acid type resin containing carboxylic acid type functional group,
(ii) A copolymer of methacrylic acid and divinylbenzene, said copolymer containing carboxylic acid-based functional groups,
(iii) A strongly acidic type of polystyrene resin containing sulfonic acid-based functional groups,
(iv) A resin of medium acidic type in polystyrene containing phosphoric acid-based functional groups, and
(v) A combination thereof.
20. The pouch composition of any of claims 1-19, wherein the ion exchange resin comprises a polyirine resin.
21. The pouch composition of any of claims 1-20, wherein the ion exchange resin is a polyirine resin.
22. The pouch composition of any of claims 1-21, wherein the nicotine-ion exchange resin combination comprises nicotine complexed with an ion exchange resin.
23. The pouch composition of any of claims 1-22, wherein the nicotine-ion exchange resin combination is nicotine complexed with an ion exchange resin.
24. The pouch composition of any of claims 1-23, wherein the nicotine-ion exchange resin combination comprises free base nicotine mixed with an ion exchange resin.
25. The pouch composition of any of claims 1-24, wherein the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 20-40% by weight of the composition, such as 25-35% by weight of the composition.
26. The pouch composition of any of claims 1-25, wherein the pouch composition comprises at least one sugar alcohol.
27. The pouch composition of any of claims 1-26, wherein the at least one sugar alcohol is selected from xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol, and mixtures thereof.
28. The pouch composition of any of claims 1-27, wherein the pouch composition comprises at least two sugar alcohols.
29. The pouch composition of any of claims 1-28, wherein the pouch composition comprises a sugar alcohol in an amount of at least 1% by weight of the composition, such as at least 2% by weight of the composition, such as at least 5% by weight of the composition, such as at least 10% by weight of the composition, such as at least 15% by weight of the composition.
30. The pouch composition of any of claims 1-29, wherein the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition.
31. The pouch composition of any of claims 1-30, wherein the pouch composition comprises at least one water insoluble fiber.
32. The pouch composition of any of claims 1-31, wherein the pouch composition comprises the water insoluble fiber in an amount of between 5 to 50% by weight of the pouch composition, such as 10-45% by weight of the pouch composition, such as 15-40% by weight of the pouch composition.
33. The pouch composition of any of claims 1-32, wherein the water insoluble fiber is a plant fiber.
34. The pouch composition of any of claims 1-33, wherein the water insoluble fiber is selected from the group consisting of wheat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, cellulose fiber, bran fiber, bamboo fiber, powdered cellulose, and combinations thereof.
35. The pouch composition of any of claims 1-34, wherein the water insoluble fiber has a water binding capacity of at least 200%, such as at least 300%, such as at least 400%.
36. The pouch composition of any of claims 1-35, wherein the water insoluble fiber has a density of 50 to 500 g/l, such as 100 to 400 g/l, such as 200 to 300 g/l.
37. The pouch composition of any of claims 1-36, wherein the pouch composition comprises a pH adjuster.
38. The pouch composition of any of claims 1-37, wherein the pouch composition comprises a pH adjuster in an amount of between 0.01 to 15% by weight of the pouch composition, such as between 0.5 to 10% by weight of the pouch composition, such as between 1 to 10% by weight of the pouch composition, such as between 5 to 10% by weight of the pouch composition.
39. The pouch composition of any of claims 1-38, wherein the pH adjustor is an alkaline pH adjustor, such as an alkaline buffer.
40. The pouch composition of any of claims 1-39, wherein the pH adjustor is a buffer, such as an alkaline buffer.
41. The pouch composition of any of claims 1-40, wherein the pH adjustor is selected from the group consisting of sodium carbonate, sodium bicarbonate, potassium carbonate, and magnesium carbonate; potassium bicarbonate; tromethamine; phosphate buffer, amino acid, or any combination thereof.
42. The pouch composition of any of claims 1-41, wherein the pH adjustor is selected from the group consisting of sodium carbonate, sodium bicarbonate, potassium carbonate, and magnesium carbonate; potassium bicarbonate; tromethamine; phosphate buffer, or any combination thereof.
43. The pouch composition of any of claims 1-42, wherein the pH adjustor is selected from the group consisting of tromethamine, an amino acid, and a phosphate buffer, or any combination thereof.
44. The pouch composition of any of claims 1-43, wherein the pH adjustor is selected from the group consisting of tromethamine and phosphate buffer or any combination thereof.
45. The pouch composition of any of claims 1-44, wherein the pH adjustor is tromethamine.
46. The pouch composition of any of claims 1-44, wherein the pH adjustor is a phosphate buffer.
47. The pouch composition of any of claims 1-43, wherein the pH adjustor is an amino acid.
48. The pouch composition of any of claims 1-47, wherein the pouch composition is adapted to release at least 30% of nicotine within 10 minutes upon exposure to the in vitro conditions described in example 7A.
49. The pouch composition of any of claims 1-48, wherein the pouch composition is adapted to release at least 25% more nicotine within 5 minutes than a corresponding pouch composition without divalent cations upon exposure to the in vitro conditions described in example 7A.
50. The pouch composition of any of claims 1-49, wherein the pouch composition comprises a humectant.
51. The pouch composition of any of claims 1-50, wherein the pouch composition comprises sodium chloride in an amount of 0.0-3.0% by weight of the pouch composition, such as 0.05-1.0% by weight of the pouch composition, such as 0.1-1.0% by weight of the pouch composition.
52. The pouch composition of any of claims 1-51, wherein the pouch composition is a non-tobacco pouch composition.
53. The pouch composition according to any of claims 1-51, wherein the pouch composition comprises less than 2.0% by weight tobacco, such as less than 1.0% by weight tobacco, such as less than 0.5% by weight tobacco, such as 0.0% by weight tobacco.
54. The pouch composition of any of claims 1-51, wherein the pouch composition comprises non-tobacco fibers.
55. The pouch composition of any of claims 1-54, wherein the pouch composition is a powdered composition.
56. An oral pouched nicotine product comprising a saliva-permeable pouch and a pouch composition according to any one of claims 1-55 enclosed in the pouch.
57. An oral packaged nicotine product according to claim 56, wherein the packaged nicotine product comprises nicotine in an amount of 0.5 to 20mg, such as 1.0 to 20mg, such as 5.0 to 15 mg.
58. The oral pouched nicotine product of claim 56 or 57, wherein the pouched nicotine product comprises a nicotine-ion exchange combination in an amount of from 1 to 100mg per pouch.
59. A pouch composition comprising
Nicotine-ion exchange resin combination, and
inorganic multivalent cations.
60. The pouch composition of claim 59, wherein the multivalent cation is selected from multivalent ions of calcium, magnesium, zinc, aluminum, barium, iron, manganese, copper, lead, cobalt, nickel, such as ca2+, mg2+, zn2+, al3+, ba2+, fe2+, fe3+, fe4+, mn2+, mn4+, cu4+, or any combination thereof.
61. The pouch composition of claim 59 or 60, wherein the multivalent cation is trivalent.
62. The pouch composition of any of claims 59-61, wherein the multivalent cation is selected from the group consisting of trivalent cations of aluminum, divalent cations of calcium, magnesium, iron, zinc, and any combination thereof.
63. The pouch composition of any of claims 59-60 or 62, wherein the multivalent cation is selected from the group consisting of divalent cations of calcium, magnesium, iron, zinc, and any combination thereof.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20207822.6 | 2020-11-16 | ||
US17/099,446 | 2020-11-16 | ||
US17/099,446 US20220151292A1 (en) | 2020-11-16 | 2020-11-16 | Nicotine pouch composition |
EP20207822.6A EP4000424B1 (en) | 2020-11-16 | 2020-11-16 | Nicotine pouch composition |
PCT/DK2021/050334 WO2022100805A1 (en) | 2020-11-16 | 2021-11-16 | Nicotine pouch composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116419682A true CN116419682A (en) | 2023-07-11 |
Family
ID=78676251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180075476.XA Pending CN116419682A (en) | 2020-11-16 | 2021-11-16 | Nicotine pouch compositions |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2023549345A (en) |
CN (1) | CN116419682A (en) |
CA (1) | CA3198533A1 (en) |
WO (1) | WO2022100805A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023106407A1 (en) * | 2021-12-09 | 2023-06-15 | 日本たばこ産業株式会社 | Composition for oral cavity and pouch product for oral cavity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11717017B2 (en) * | 2017-04-24 | 2023-08-08 | Swedish Match North Europe Ab | Flavoured moist oral pouched nicotine product comprising triglyceride |
US11406630B2 (en) * | 2017-06-23 | 2022-08-09 | Ncp Nextgen A/S | Nicotine pouch |
KR20210122776A (en) * | 2019-02-01 | 2021-10-12 | 스웨디쉬 매치 노스 유럽 에이비 | Oral nicotine products containing pH adjusters |
-
2021
- 2021-11-16 WO PCT/DK2021/050334 patent/WO2022100805A1/en active Application Filing
- 2021-11-16 CN CN202180075476.XA patent/CN116419682A/en active Pending
- 2021-11-16 JP JP2023527692A patent/JP2023549345A/en active Pending
- 2021-11-16 CA CA3198533A patent/CA3198533A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3198533A1 (en) | 2022-05-19 |
WO2022100805A1 (en) | 2022-05-19 |
JP2023549345A (en) | 2023-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11096412B2 (en) | Nicotine pouch composition and pouch comprising such | |
US11406630B2 (en) | Nicotine pouch | |
US11963944B2 (en) | Cannabinoid pouch | |
US11166935B2 (en) | Cannabinoid pouch | |
DK180339B1 (en) | Nicotine pouch composition and pouch comprising such | |
CN116419682A (en) | Nicotine pouch compositions | |
EP4000424B1 (en) | Nicotine pouch composition | |
US20220151292A1 (en) | Nicotine pouch composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |